1
|
Kiani B, Mario Martin B, Cadavid Restrepo A, Mayfield HJ, Skinner E, Karina Maldonado Alcaíno A, Nilles EJ, Lau CL, Sartorius B. A study protocol for developing a spatial vulnerability index for infectious diseases of poverty in the Caribbean region. Glob Health Action 2025; 18:2461867. [PMID: 39930987 PMCID: PMC11816615 DOI: 10.1080/16549716.2025.2461867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2024] [Accepted: 01/29/2025] [Indexed: 02/14/2025] Open
Abstract
Infectious diseases of poverty (IDoP) affect disproportionately resource-limited and marginalized populations, resulting in spatial patterns of vulnerability across various geographical areas. Currently, no spatial indices exist to quantify vulnerability to IDoP at a fine geographical level within countries, such as municipalities or provinces. Without such an index, policymakers cannot effectively allocate resources or target interventions in the most vulnerable areas. This protocol aims to specify a methodological approach to measure spatial variation in vulnerability to IDoP. We will evaluate this methodological approach using surveillance and seroprevalence data from the Dominican Republic (DR) as part of a broader effort to develop a regional index for the Caribbean region. The study will consist of three main components. The first component involves identifying the relevant factors associated with IDoP in the Caribbean region through a scoping review, supplemented by expert-elicited opinion. The second component will apply a Fuzzy Analytic Hierarchy Process to weigh the aforementioned factors and develop a spatial composite index, using open data and available national surveys in the DR. In the final component, we will evaluate and validate the index by analysing the prevalence of at least three IDoPs at a fine-grained municipal level in the DR, using seroprevalence data from a 2021 national field study and other national surveillance programs. The spatial vulnerability index framework developed in this study will assess the degree of vulnerability to IDoP across different geographical scales, depending on data availability in each country.
Collapse
Affiliation(s)
- Behzad Kiani
- UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia
| | - Beatris Mario Martin
- UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia
| | - Angela Cadavid Restrepo
- School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia
| | - Helen J. Mayfield
- UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia
| | - Eloise Skinner
- UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia
| | - Ana Karina Maldonado Alcaíno
- UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia
| | - Eric J. Nilles
- Department of Emergency Medicine, Brigham and Women Hospital, Boston, MA, USA
- Infectious Diseases and Epidemics Program, Harvard Medical School, Boston, MA, USA
- Infectious Diseases and Epidemics Program, Harvard Humanitarian Initiative, Cambridge, MA, USA
| | - Colleen L. Lau
- UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia
| | - Benn Sartorius
- UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia
| |
Collapse
|
2
|
Tiwari HK, Tan DK, Chinda C, My DNT, Hoang HTT, Keonam K, Huong LQ, Chanvatanak L, Virak M, Tram NT, Soulinthone N, Phuc PD, Nguyen TTH, Tra VTT, Beardsley J. Challenges and opportunities for AMR research in the ASEAN following the One Health approach. One Health 2025; 20:101001. [PMID: 40123915 PMCID: PMC11927718 DOI: 10.1016/j.onehlt.2025.101001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2024] [Revised: 11/08/2024] [Accepted: 02/19/2025] [Indexed: 03/25/2025] Open
Abstract
Background Antimicrobial resistance (AMR) has emerged as a significant global challenge and Southeast Asia with rapid economic and population growth faces substantial challenge in dealing with emerging infectious diseases and antimicrobial resistance. Here we present the recommendations of a workshop that explored the challenges and opportunities for One Health approach towards AMR research in three countries of AEAN, namely, Cambodia, Laos, and Vietnam. Methods A workshop was organised in Hanoi, Vietnam in August 2023, involving participants involved in AMR research across varied sectors from three participating countries to prioritise the strategies that can be implemented in the region to fructify the One Health approach to tackle AMR. A modified Delphi approach was used to prioritise the top 10 Global Priority Research Questions for the region as developed by the Quadripartite (FAO, WHO, WOAH and UNEP). An iterative process was adopted to map priorities according to their impact and feasibility of application. Results Collaborative initiatives, such as a common platform for listing the research goals, a web-based surveillance mechanism, and an enhanced AMR awareness curricula were identified as the steps forward. A consensus statement highlighting the critical needs for improved technical and infrastructure capacity, collaboration between sectors, increased funding, and systematic data analysis was drafted. Discussion The participating countries have National Action Plans guided by the World Health Organization's Global Action Plan on AMR, but limited collaboration between human health and other sectors has impeded the benefits that One Health approach may achieve in the region. The recommendations include the need for improved technical and infrastructure capacity, and data collection across One Health sectors, besides increasing awareness at multiple levels. Conclusion A collaborative and coordinated effort to apply One Health initiatives for tackling AMR in the ASEAN region is imperative. The workshop formulated a roadmap for future direction by identifying priorities aimed at enhancing collaboration, addressing infrastructure gaps, and contributing to an effective intervention in the fight against AMR in the region.
Collapse
Affiliation(s)
- Harish Kumar Tiwari
- Sydney Medical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia
- School of Health Science and Technology, Indian Institute of Technology Guwahati, Guwahati, Assam, India
- DBT Wellcome Trust India Alliance Intermediate Fellow, Hyderabad, Telangana, India
| | - Daniel K.Y. Tan
- Sydney Medical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia
| | - Chhe Chinda
- National Institute of Science Technology and Innovation, Cambodia
| | - Duong Nu Tra My
- Sydney Medical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia
- Woolcock Institute, Viet Nam
| | | | | | | | | | - Mot Virak
- National Institute of Public Health, Cambodia
| | | | | | - Pham Duc Phuc
- Centre for Public Health and Ecosystem Research, Hanoi University of Public Health, Viet Nam
| | - Thi Thu Hoai Nguyen
- International University, Vietnam National University of Ho Chi Minh City, Viet Nam
| | | | - Justin Beardsley
- Sydney Medical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia
| |
Collapse
|
3
|
Niederberger M, Sonnberger M. The participation of lifeworld experts in Delphi processes: A reflection on method and practice. MethodsX 2025; 14:103274. [PMID: 40230552 PMCID: PMC11995758 DOI: 10.1016/j.mex.2025.103274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2025] [Accepted: 03/18/2025] [Indexed: 04/16/2025] Open
Abstract
Delphi studies have established themselves in the health sciences as a means to systematically and, ideally, synthesize expert opinions into a consensus on concrete issues. As participatory health research increases in relevance, lifeworld experts (e.g., patients, caregiving relatives) are being included in Delphi surveys and their opinions placed alongside those of professional and scientific experts. Looking at the theory and methodology, we discuss the opportunities and challenges concerning result quality and derive practical implications for conducting Delphi studies involving lifeworld experts alongside scientific and/or professional experts. Delphi techniques are understood here to be social interaction processes whose outcomes are a result of the participating experts' conscious, cognitive judgment processes, and also shaped by individual, situational and cultural factors. The more heterogeneous the expert panel, in particular when lifeworld experts are participating, the more these influences vary. Expert panel composition and how diversity is handled prove significant to Delphi study results. Our argument is based on an in-depth analysis of a systematic review of Delphi studies with lifeworld experts. We found that the inclusion of lifeworld experts in Delphi studies usually occurs relatively unsystematically and, furthermore, that results are not analysed separately according to expert group, although there would be good reasons for this. We have oriented the reporting here on PRISMA. To enhance the outcomes of Delphi studies that incorporate lifeworld experts alongside scientific and/or professional experts, we put forward specific recommendations that address potential biases arising from the participation of lifeworld experts.
Collapse
Affiliation(s)
- Marlen Niederberger
- PH Schwäbisch Gmünd, Institut für Gesundheitswissenschaften, Abt. Für Forschungsmethoden in der Gesundheitsförderung und Prävention, Oberbettringer Str. 200, Schwäbisch, Gmünd 73525, Germany
| | - Marco Sonnberger
- University of Stuttgart, Department of Sociology of Technology, Risk and Environment (SOWI V), Seidenstrasse 36, Stuttgart 70174, Germany
| |
Collapse
|
4
|
Petry Moecke D, Holyk T, Campbell KL, Ho K, Camp PG. Best practice recommendations for physiotherapists providing telerehabilitation to First Nations people: a modified Delphi study. Physiotherapy 2025; 127:101464. [PMID: 39919644 DOI: 10.1016/j.physio.2025.101464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2024] [Revised: 12/19/2024] [Accepted: 01/12/2025] [Indexed: 02/09/2025]
Abstract
OBJECTIVES This study aimed to develop best practice recommendations for physiotherapists providing telerehabilitation to First Nations people. DESIGN Modified Delphi study. PARTICIPANTS Eighteen experts from four groups were selected: (a) physiotherapists who provide telerehabilitation to First Nations people, (b) Carrier Sekani Family Services leaders (CSFS, First Nations-led health organization/research partners), (c) telehealth experts from British Columbia (BC), Canada, and (d) First Nations individuals (end users) with experience in telerehabilitation. METHODS Panelists rated recommendations on telehealth best practices in two rounds using an online questionnaire. Recommendations were synthesized from a scoping review and two qualitative studies. Each statement was rated on a four-point Likert scale indicating whether it was essential, useful, not useful, or unnecessary for inclusion in the best practices. Statements endorsed by ≥80% of panel members were considered for inclusion in the final document. RESULTS Following the Delphi process, 77 recommendations covering foundational components, information technology utilization, professional expertise, therapeutic relationships, cultural safety, and the telehealth visit were validated for inclusion in the policy document. Participants also validated the methodology. CONCLUSION The recommendations offer a valuable resource for continuing education and professional development, empowering physiotherapists to enhance their skills and competencies in delivering culturally competent telerehabilitation to the First Nations population. The adoption of these best practices ensures that First Nations people are getting the best standard of care, potentially enhancing uptake and experiences with telehealth. It also enables healthcare organizations and policymakers to monitor adherence to established standards and identify areas for improvement. CONTRIBUTION OF THE PAPER.
Collapse
Affiliation(s)
- Débora Petry Moecke
- Rehabilitation Sciences Graduate Program, University of British Columbia, Canada.
| | | | | | - Kendall Ho
- Department of Emergency Medicine, University of British Columbia, Canada.
| | - Pat G Camp
- Department of Physical Therapy, University of British Columbia, Canada.
| |
Collapse
|
5
|
Mahl D, Schäfer MS, Voinea SA, Adib K, Duncan B, Salvi C, Novillo-Ortiz D. Responsible artificial intelligence in public health: a Delphi study on risk communication, community engagement and infodemic management. BMJ Glob Health 2025; 10:e018545. [PMID: 40409762 DOI: 10.1136/bmjgh-2024-018545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2024] [Accepted: 04/08/2025] [Indexed: 05/25/2025] Open
Abstract
INTRODUCTION Artificial intelligence (AI) holds the potential to fundamentally transform how public health authorities use risk communication, community engagement and infodemic management (RCCE-IM) to prepare for, manage and mitigate public health emergencies. As research on this crucial transformation remains limited, we conducted a modified Delphi study on the impact of AI on RCCE-IM. METHODS In two successive surveys, 54 experts-scholars with expertise in public health, digital health, health communication, risk communication and AI, as well as RCCE-IM professionals-from 27 countries assessed opportunities, challenges and risks of AI, anticipated future scenarios, and identified principles and actions to facilitate the responsible use of AI. The first Delphi round followed an open, exploratory approach, while the second sought to prioritise and rank key findings from the initial phase. Qualitative thematic analysis and statistical methods were applied to evaluate responses. RESULTS According to the expert panel, AI could be highly beneficial, particularly for risk communication (eg, tailoring messages) and infodemic management (eg, social listening), while its utility for fostering community engagement was viewed more critically. Challenges and risks affect all three components of RCCE-IM equally, with algorithmic bias and privacy breaches being of particular concern. Panellists anticipated both optimistic (eg, democratisation of information) and pessimistic (eg, erosion of public trust) future scenarios. They identified seven principles for the responsible use of AI for public health practices, with equity and transparency being the most important. Prioritised actions ranged from regulatory measures, resource allocation and feedback loops to capacity building, public trust initiatives and educational training. CONCLUSION To responsibly navigate the multifaceted opportunities, challenges and risks of AI for RCCE-IM in public health emergencies, clear guiding principles, ongoing critical evaluation and training as well as societal collaboration across countries are needed.
Collapse
Affiliation(s)
- Daniela Mahl
- Department of Communication and Media Research, University of Zurich, Zurich, Switzerland
| | - Mike S Schäfer
- Department of Communication and Media Research, University of Zurich, Zurich, Switzerland
| | | | - Keyrellous Adib
- World Health Organization Regional Office for Europe, Copenhagen, Denmark
| | - Ben Duncan
- World Health Organization Regional Office for Europe, Copenhagen, Denmark
| | - Cristiana Salvi
- World Health Organization Regional Office for Europe, Copenhagen, Denmark
| | | |
Collapse
|
6
|
Teschner D, Knop J, Piehl C, Schubert T, Witzke O. Patient Number and Treatment Patterns in Cytomegalovirus Viremia and Disease Following Solid Organ and Hematopoietic Stem Cell Transplantation in Germany: Results of a Delphi Consensus Study. Adv Ther 2025:10.1007/s12325-025-03210-x. [PMID: 40402379 DOI: 10.1007/s12325-025-03210-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2024] [Accepted: 04/16/2025] [Indexed: 05/23/2025]
Abstract
INTRODUCTION Management of cytomegalovirus (CMV) viremia/disease in transplant recipients may be complicated by toxicities and resistance to conventional antivirals, adding to the overall healthcare burden. Despite advances in analyzing real-world data in current years, little is known about refractory and resistant CMV. This study therefore aimed to characterize treatment patterns and patient numbers with special focus on refractory and resistant CMV. METHODS Two classical three-round Delphi consensus panels with German clinical experts in CMV following solid organ transplantations (SOT) and hematopoietic stem cell transplantations (HSCT) were held between October and December 2021 using online questionnaires. Consensus was defined as agreement of 75% of participants. RESULTS Following SOT, experts agreed that on average 65% of SOT patients are not affected by CMV at all, while 35% of patients experience CMV viremia or disease. Of SOT patients treated with antiviral therapies, experts agreed that 90% respond to their first-line treatment and 10% do not. For HSCT, experts agreed that 62% of patients experience no CMV, while 38% of patients are diagnosed with either CMV viremia or CMV disease. It was further estimated that 23% HSCT patients receiving antiviral treatment do not respond to their first-line CMV treatment. Experts reached consensus on the reasons for non-response, suggesting that among non-responders, 55% were intolerant, while 45% of non-responders were refractory/resistant to first-line treatment. CONCLUSION Based on the current incidence of transplantations in Germany, experts estimated that 103 SOT and 225 HSCT patients need second-line CMV treatment annually.
Collapse
Affiliation(s)
- Daniel Teschner
- Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
- Department of Hematology, and Medical Oncology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - Jana Knop
- Takeda Pharma Vertrieb GmbH & Co. KG, Potsdamer Str. 125, 10783, Berlin, Germany.
| | - Christian Piehl
- Takeda Pharma Vertrieb GmbH & Co. KG, Potsdamer Str. 125, 10783, Berlin, Germany
| | | | - Oliver Witzke
- Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany
| |
Collapse
|
7
|
Xiao W, Huang B, Fang H, Li Y, Chen W, Ye T. The Influence of Cognitive and Affective Trust on the Utilization of Family Doctor Services: A Chinese Cross-Sectional Survey Based on McAllister's Theory. Patient Prefer Adherence 2025; 19:1463-1473. [PMID: 40406510 PMCID: PMC12095426 DOI: 10.2147/ppa.s504605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/15/2024] [Accepted: 04/29/2025] [Indexed: 05/26/2025] Open
Abstract
Purpose This study explores the impact of cognitive and affective trust on the utilization of family doctor services based on McAllister's theory. It also analyzes the factors influencing these forms of trust. Patients and Methods A cross-sectional study using stratified random sampling gathered data from 325 adult patients registered with family doctors in six community health centers in Wuhan, China. PLS-SEM was employed to examine the relationships among cognitive trust, affective trust, and the utilization of family doctor services. Logistic regression was utilized to identify the factors influencing cognitive and affective trust. Results Higher cognitive trust significantly influenced affective trust (β = 0.549, p < 0.01) and was positively associated with service utilization (β = 0.524, p < 0.01). Affective trust also showed a positive association with service utilization (β= 0.481, p < 0.01). Occupation and marital status were found to have a significant impact on both cognitive and affective trust. Specifically, professional and technical workers(OR=9.699, p=0.001;OR=2.309, p=0.011) and non-married individuals(OR=7.591, p=0.001;OR=2.737, p=0.002) demonstrated higher trust levels. Conclusion The study reveals the importance of cognitive and affective trust in patient engagement with family doctor services. It suggests that family doctors should enhance their professionalism while also demonstrating emotional care to improve overall healthcare quality. Additionally, attention should be given to the influence of factors such as occupation and marital status on patients' trust in family doctors.
Collapse
Affiliation(s)
- Wenqi Xiao
- School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Bo Huang
- Research Center for Rural Health Service, Key Research Institute of Humanities & Social Sciences of Hubei Provincial Department of Education, Wuhan, People’s Republic of China
| | - Huiyan Fang
- School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Yilin Li
- School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Weizhuo Chen
- School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Ting Ye
- School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
- Research Center for Rural Health Service, Key Research Institute of Humanities & Social Sciences of Hubei Provincial Department of Education, Wuhan, People’s Republic of China
| |
Collapse
|
8
|
Burke MJ, Ahmed YE, Li Z, Sanchez K, Winston A, Broadhurst P, Haas B, Steinberg RJ, Wasilewski MB, Silverberg ND, Robinson LR, Hitzig SL. Identifying mild traumatic brain injury in the post-acute polytrauma setting: a scoping review of diagnostic approaches and screening tools. Brain Inj 2025; 39:445-456. [PMID: 39748196 DOI: 10.1080/02699052.2024.2443771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2024] [Revised: 11/27/2024] [Accepted: 12/13/2024] [Indexed: 01/04/2025]
Abstract
OBJECTIVE Mild traumatic brain injury (mTBI) is frequently overlooked in polytrauma patients due to the overshadowing of more severe injuries, a fact that makes its identification in post-acute settings challenging since symptoms overlap with other conditions and no validated diagnostic tools exist. To address this gap, this scoping review explored the literature on mTBI diagnosis in post-acute civilian polytrauma settings. METHODS By utilizing the Arksey and O'Malley framework and PRISMA-ScR guidelines, the review focused on studies from 2010 to 2024 related to delayed mTBI diagnosis in adults. Of the 696 studies identified, only six met the inclusion criteria, highlighting the limited research in this area. RESULTS The review assessed various diagnostic tools including the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), neuropsychological tests, advanced imaging, and oculomotor assessments. However, these tools are limited in their ability to confirm whether an mTBI has occurred. The American Congress of Rehabilitation Medicine's updated mTBI criteria may offer the best diagnostic potential but require validation. CONCLUSION According to the findings, there is a significant gap in validated diagnostic tools for mTBI in post-acute settings, which may negatively affect patient outcomes. Developing and validating effective screening tools for mTBI in the post-acute polytrauma setting should be the priority of future research in this area.
Collapse
Affiliation(s)
- Matthew J Burke
- Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- Department of Psychiatry and Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Yomna E Ahmed
- St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
| | - Zoe Li
- St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
| | - Kris Sanchez
- St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
| | - Alexander Winston
- St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
| | - Peter Broadhurst
- St. John's Rehab Hospital, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
| | - Barbara Haas
- Tory Trauma Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- Department of Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Rosalie J Steinberg
- Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- St. John's Rehab Hospital, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Marina B Wasilewski
- St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- Department of Occupational Science and Occupational Therapy, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- Rehabilitation Sciences Institute, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Noah D Silverberg
- Rehabilitation Sciences Institute, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- Rehabilitation Research Program, Centre for Aging SMART, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada
- Division of Physical Medicine and Rehabilitation, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Lawrence R Robinson
- St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- St. John's Rehab Hospital, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- Department of Occupational Science and Occupational Therapy, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- Division of Physical Medicine and Rehabilitation, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Sander L Hitzig
- St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- Department of Occupational Science and Occupational Therapy, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- Rehabilitation Sciences Institute, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|
9
|
Xie F, Liu R, Sun P, Zheng L, Wang K, Chen J, Hu R. The association between clinicians' legal literacy and the service quality of primary healthcare - evidence from the Greater Bay Area study, China. BMC MEDICAL EDUCATION 2025; 25:681. [PMID: 40346498 PMCID: PMC12065181 DOI: 10.1186/s12909-025-07243-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/25/2024] [Accepted: 04/25/2025] [Indexed: 05/11/2025]
Abstract
BACKGROUND In healthcare facilities, clinicians' legal literacy may influence the implementation of the law, which is one of the determinants of service quality. Studies regarding the association between clinicians' legal literacy and the quality of services provided by medical facilities were insufficient. OBJECTIVE To evaluate the association between clinicians' legal literacy and the quality of primary healthcare services in the Greater Bay Area, China. METHODS This study was a cross-sectional design. A general linear model was employed to assess the association between clinicians' legal literacy and the service quality of community health service institutions (CHSIs), controlling for confounding variables. From September 2023 to April 2024, 477 physicians and nurses from 58 CHSIs in the Greater Bay Area, China, engaged in this study. A self-administered questionnaire was utilized to evaluate the clinicians' legal literacy, encompassing legal knowledge, legal attitude, and legal compliance, which was validated by the Delphi method. The National Committee for Quality Assurance Patient-Centered Medical Home (NCQA-PCMH) was employed to assess the service quality of CHSIs. RESULTS In the adjusting models, higher scores of legal literacy were related to higher scores of NCQA-PCMH significantly (aβ = 1.360, 95%CI = 0.091-2.630, P = 0.036). Among the six domains of PCMH, PCMH1 (aβ = 0.184, 95%CI = 0.080-0.287, P = 0.001), PCMH3 (aβ = 0.330, 95%CI = 0.052-0.608, P = 0.020), and PCMH4 (aβ = 0.660, 95%CI = 0.256-1.063, P = 0.001) were found to be related to clinicians' legal literacy. CONCLUSION This study demonstrated an association between clinicians' legal literacy and the quality of services provided by primary healthcare institutions. The findings offered novel evidence for policymakers and administrators of medical institutions to enhance clinicians' legal literacy with continuing medical education programs, which could improve the overall management framework of contemporary medical facilities.
Collapse
Affiliation(s)
- Fang Xie
- School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong, 510080, China
| | - Ruqing Liu
- School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong, 510080, China
| | - Peng Sun
- Shenzhen Nanshan District Maternity & Child Healthcare Hospital, Shenzhen, 518052, China
| | - Lingling Zheng
- Department of Computer Information Science, State Key Laboratory of Internet of Things for Smart City, University of Macau, Macau, China
- Department of Computational Biology and Medical Big Data, Shenzhen University of Advanced Technology, Shenzhen, China
| | - Kaixuan Wang
- Faculty of Social Science, Macao Polytechnic University, Macao, China
| | - Jianli Chen
- School of Public Health, Southeast University, Nanjing, Jiangsu, 210009, China
| | - Ruwei Hu
- School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong, 510080, China.
- School of Law, Sun Yat-Sen University, Guangdong, Guangzhou, 510275, China.
| |
Collapse
|
10
|
Sánchez-Arizcuren R, García-Uceda E, Oliván-Blázquez B. Indicators to evaluate the labor insertion of people with disabilities in conventional companies in Spain: A Delphi study. PLoS One 2025; 20:e0322814. [PMID: 40343981 PMCID: PMC12063877 DOI: 10.1371/journal.pone.0322814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2024] [Accepted: 03/27/2025] [Indexed: 05/11/2025] Open
Abstract
INTRODUCTION The level of labor integration of people with disability (PwD) is notably lower than that of people without disabilities. In order to evaluate the success of the labor market integration of people with disabilities, it is necessary to establish a series of indicators that go beyond hiring rates. Hence, the objective of this study is to develop a list of indicators with their specified individual weight that will serve to evaluate the success of the labor market insertion of PwD in conventional companies. METHODOLOGY The Delphi method was used. In Phase 1, an open-ended questionnaire was distributed to 48 human resources and disability experts. From this qualitative analysis, a list of 52 indicators was drawn up and the experts were asked to evaluate their importance using a scale from 0 to 10 points. The convergence of opinion was obtained in the third phase. To evaluate the degree of stability of the experts' responses in the different phases, the Wilcoxon test was applied. Finally, a factor analysis was carried out in relation to the indicators. RESULTS After the development of the three phases and the factor analysis, a list of 26 indicators was obtained to measure the success of inclusive employability, structured in four factors: Work Performance, Labor Management, Social and Organizational Impact, Competency Assessment. CONCLUSIONS This project has provided a list of indicators that can be the basis for the creation of a scale to assess the successful integration of people with disabilities in the conventional company.
Collapse
|
11
|
Van Houtven CH, Boucher NA, Decosimo K, Whitfield CL, Dennis PA, Smith VA, Stechuchak KM, Kaufman BG, Hastings SN, Ozdemir S, Sperber NR. A Proposed Universal "Home Time" Quality of Life Measure for Older Adults. J Am Geriatr Soc 2025. [PMID: 40341521 DOI: 10.1111/jgs.19506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2024] [Revised: 04/01/2025] [Accepted: 04/06/2025] [Indexed: 05/10/2025]
Abstract
BACKGROUND Researchers and insurers use "home time," or an individual's time at home compared to time in different health care settings, as a population-level quality of life (QoL) or quality of care measure. With varying definitions, it is unknown which components of a home time measure most closely reflect QoL. Our objective is to develop a person-centered universal home time measure agnostic to condition. METHODS We used an iterative, structured approach based on Delphi methods to obtain expert input on what a measure should include, using qualitative and quantitative evidence from prior work. A total of 28 expert panelists, including Veterans Affairs (VA) leaders, clinician researchers, and non-clinician researchers, participated. In the first round, panelists voted on components (settings, weights, timeframes) to include in a home time measure. In the second round, panelists discussed results. The third round was final voting and explanations of choices and caveats. RESULTS Qualitative and quantitative data suggested that emergency department, inpatient care, and post-acute care settings all affect older adults' QoL in different ways, supporting inclusion; 75% of the experts endorsed all settings, and discussion suggested that future work should limit ED days to visits resulting in an inpatient admission. Our data did not reveal a clear indication for weighting settings: 56% of the expert panel suggested continuing to explore the use of weights to arrive at values that would reflect qualitative differences in settings, and 44% did not support the use of any weights. Our 6-month models resulted in QoL outcomes for all settings, and 30% of experts endorsed a 6-month timeframe, while 65% said that timeframe would depend on the situation. CONCLUSION A "1.0" universal person-centered home time measure that reflects QoL should include days in the emergency department, inpatient care, and post-acute care. Expert input revealed domains of agreement and disagreement. Future validation efforts that incorporate expert input are needed to iterate and arrive at the optimal measure.
Collapse
Affiliation(s)
- Courtney H Van Houtven
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
- Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA
- Duke-Margolis Institute for Health Policy, Duke University, Durham, North Carolina, USA
| | - Nathan A Boucher
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
- Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA
- Duke-Margolis Institute for Health Policy, Duke University, Durham, North Carolina, USA
- Sanford School of Public Policy, Duke University, Durham, North Carolina, USA
- Center for the Study of Aging, Duke University School of Medicine, Durham, North Carolina, USA
- Division of Geriatrics, Department of Medicine, Duke University, Durham, North Carolina, USA
| | - Kasey Decosimo
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
| | - Chelsea L Whitfield
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
| | - Paul A Dennis
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
- Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA
| | - Valerie A Smith
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
- Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA
- Sanford School of Public Policy, Duke University, Durham, North Carolina, USA
| | - Karen M Stechuchak
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
| | - Brystana G Kaufman
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
- Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA
- Duke-Margolis Institute for Health Policy, Duke University, Durham, North Carolina, USA
| | - S Nicole Hastings
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
- Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA
- Center for the Study of Aging, Duke University School of Medicine, Durham, North Carolina, USA
- Division of General Internal Medicine, Department of Medicine, Duke University, Durham, North Carolina, USA
- Geriatrics Research, Education, and Clinical Center, Durham Virginia Health Care System, Durham, North Carolina, USA
| | - Semra Ozdemir
- Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA
- Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA
| | - Nina R Sperber
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
- Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA
| |
Collapse
|
12
|
Hodge S, Lowery J, Bowling F, Haque A, Riding D, Ghosh J, PREPARE Collaborative. PRE-oPerative Assessment for Patients with Chronic Limb ThReatening IschEmia (PREPARE): A Multinational Delphi Consensus. Ann Vasc Surg 2025; 119:79-90. [PMID: 40334977 DOI: 10.1016/j.avsg.2025.04.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2025] [Revised: 04/09/2025] [Accepted: 04/09/2025] [Indexed: 05/09/2025]
Abstract
BACKGROUND Chronic limb-threatening ischemia (CLTI) presents significant challenges in both diagnosis and management, with a lack of standardized preoperative assessment and optimization frameworks. This study aimed to establish a contemporary consensus among vascular specialists on the perioperative care of CLTI patients across diverse health-care systems. METHODS A modified Delphi methodology was used, involving iterative rounds of consultation with 42 expert vascular surgeons from the United Kingdom, Ireland, Australia, and New Zealand. Four broad domains were explored: availability of services, preoperative assessment, perioperative optimization, and the role of multidisciplinary teams (MDTs). Consensus was defined as ≥70% agreement RESULTS: A total of 59 consensus statements were established, covering key areas such as rapid access clinics, the value of preoperative investigations and anemia. Unanimous agreement was reached regarding the necessity of clear referral pathways, and a strong majority supported the importance of MDTs in complex cases. However, significant uncertainty remained about the utility of existing risk prediction models, with only 53% endorsing tools like the American College of Surgeons Risk Calculator. Notably, 81% agreed that if preoperative investigations could change the type of intervention a patient received, this investigation should be performed prior to surgery even at the expense of delayed intervention. CONCLUSION This Delphi consensus study highlights the complexity in managing patients with CLTI and the necessity of a multifaceted, interdisciplinary approach to preoperative care. The findings advocate for improved primary care management, selective use of preoperative investigations and emphasizes the importance of interdisciplinary care. While consensus was reached on several key aspects of care, the study highlights ongoing uncertainties around risk prediction and cardiac stress testing therefore highlighting the need for further research to validate current tools and practices. These results lay the groundwork for future clinical guidelines aimed at reducing practice variability and improving patient outcomes.
Collapse
Affiliation(s)
- Stacie Hodge
- Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, Manchester, UK; Manchester Academic Vascular Research and Innovation Centre (MAVRIC), Manchester University NHS Foundation Trust, Manchester, UK.
| | - Jane Lowery
- Manchester University NHS Foundation Trust, Department of Anaesthesia, Manchester, UK
| | - Frank Bowling
- Manchester Academic Vascular Research and Innovation Centre (MAVRIC), Manchester University NHS Foundation Trust, Manchester, UK; Faculty of Biology, Medicine and Health, School of Medical Sciences, University of Manchester, Manchester, UK
| | - Adam Haque
- Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, Manchester, UK; Manchester Academic Vascular Research and Innovation Centre (MAVRIC), Manchester University NHS Foundation Trust, Manchester, UK
| | - David Riding
- Manchester Academic Vascular Research and Innovation Centre (MAVRIC), Manchester University NHS Foundation Trust, Manchester, UK
| | - Jonathan Ghosh
- Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, Manchester, UK; Manchester Academic Vascular Research and Innovation Centre (MAVRIC), Manchester University NHS Foundation Trust, Manchester, UK
| | | |
Collapse
|
13
|
Pügge S, Dukic-Ott A, Baumgärtel J, Jünger S, Bausewein C, Rémi C. Off-label drug use in palliative medicine: Delphi study for the consensus of evidence-based treatment recommendations. Palliat Med 2025; 39:530-542. [PMID: 40088119 PMCID: PMC12033383 DOI: 10.1177/02692163251323123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/17/2025]
Abstract
BACKGROUND Off-label use of drugs is an integral part of everyday clinical practice in palliative medicine. However, it is associated with many uncertainties, that is, drug therapy safety or legal issues including cost coverage. Healthcare professionals often lack time and resources for comprehensive literature search and patient-specific risk-benefit analyses. AIM The aim of this project is to develop, evaluate and rate agreement/disagreement on treatment recommendations for off-label use in adult palliative medicine. DESIGN Online Delphi study with two rounds each to rate agreement/disagreement with treatment recommendations for off-label use in adult palliative medicine. An international expert panel consisting of physicians, pharmacists and nurses working in palliative care evaluated previously developed recommendations based on the best available evidence. SETTING /participants:Professionals (physicians, pharmacists, nursing staff) working in inpatient and home palliative care involved in the medication process were recruited as experts to participate. Between 64 and 75 experts participated in the first two Delphi studies. RESULTS A total of 64/68 recommendations on 21 drugs and 14 applications were agreed upon. Topics related to routes of administration as well as indications for sialorrhea, bronchorrhea, xerostomia, pruritus, singultus, fistula, gastroparesis and hot flashes. Recommendations that reached consensus are available to health care professionals via a free of charge database. CONCLUSION For many off-label use applications, it is likely that there will be no registration studies and therefore no drug approvals in the future. The consensus-based recommendations are intended to facilitate individual treatment planning for prescribers and to enable a more reflected handling of off-label use.
Collapse
Affiliation(s)
- Stefanie Pügge
- Department of Palliative Medicine, LMU University Hospital, Ludwig-Maximilians-University in Munich, Munich, Germany
| | - Aleksandra Dukic-Ott
- Department of Palliative Medicine, LMU University Hospital, Ludwig-Maximilians-University in Munich, Munich, Germany
| | - Julian Baumgärtel
- Department of Palliative Medicine, LMU University Hospital, Ludwig-Maximilians-University in Munich, Munich, Germany
| | - Saskia Jünger
- Department of Health Sciences, Hochschule Bochum, Bochum, Germany
| | - Claudia Bausewein
- Department of Palliative Medicine, LMU University Hospital, Ludwig-Maximilians-University in Munich, Munich, Germany
| | - Constanze Rémi
- Department of Palliative Medicine, LMU University Hospital, Ludwig-Maximilians-University in Munich, Munich, Germany
| |
Collapse
|
14
|
Metwaly A, Kriaa A, Hassani Z, Carraturo F, Druart C, Arnauts K, Wilmes P, Walter J, Rosshart S, Desai MS, Dore J, Fasano A, Blottiere HM, Maguin E, Haller D. A Consensus Statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome research. Nat Rev Gastroenterol Hepatol 2025; 22:343-356. [PMID: 40033063 DOI: 10.1038/s41575-025-01041-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/17/2025] [Indexed: 03/05/2025]
Abstract
The gut microbiome comprises trillions of microorganisms and profoundly influences human health by modulating metabolism, immune responses and neuronal functions. Disruption in gut microbiome composition is implicated in various inflammatory conditions, metabolic disorders and neurodegenerative diseases. However, determining the underlying mechanisms and establishing cause and effect is extremely difficult. Preclinical models offer crucial insights into the role of the gut microbiome in diseases and help identify potential therapeutic interventions. The Human Microbiome Action Consortium initiated a Delphi survey to assess the utility of preclinical models, including animal and cell-based models, in elucidating the causal role of the gut microbiome in these diseases. The Delphi survey aimed to address the complexity of selecting appropriate preclinical models to investigate disease causality and to study host-microbiome interactions effectively. We adopted a structured approach encompassing a literature review, expert workshops and the Delphi questionnaire to gather insights from a diverse range of stakeholders. Experts were requested to evaluate the strengths, limitations, and suitability of these models in addressing the causal relationship between the gut microbiome and disease pathogenesis. The resulting consensus statements and recommendations provide valuable insights for selecting preclinical models in future studies of gut microbiome-related diseases.
Collapse
Affiliation(s)
- Amira Metwaly
- Chair of Nutrition and Immunology, TUM School of Life Sciences, Technical University Munich, Freising, Germany
- ZIEL Institute for Food & Health, Technical University Munich, Freising, Germany
| | - Aicha Kriaa
- Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France
| | | | - Federica Carraturo
- European Biomedical Research Institute of Salerno (EBRIS), Salerno, Italy
| | | | - Kaline Arnauts
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
| | - Paul Wilmes
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
- Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
| | - Jens Walter
- APC Microbiome Ireland, School of Microbiology, and Department of Medicine, University College Cork, Cork, Ireland
| | - Stephan Rosshart
- Department of Microbiome Research, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany
- Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany
| | - Mahesh S Desai
- Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg
| | - Joel Dore
- Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France
- Université Paris-Saclay, INRAE, MetaGenoPolis, Jouy-en-Josas, France
| | - Alessio Fasano
- European Biomedical Research Institute of Salerno (EBRIS), Salerno, Italy
- Department of Paediatric Gastroenterology and Nutrition, Mucosal Immunology and Biology Research Center,Massachusetts General Hospital Brigham, Harvard Medical School, Boston, MA, USA
| | - Hervé M Blottiere
- Université Paris-Saclay, INRAE, MetaGenoPolis, Jouy-en-Josas, France
- Nantes Université, INRAE, UMR1280, PhAN, Nantes, France
| | - Emmanuelle Maguin
- Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
| | - Dirk Haller
- Chair of Nutrition and Immunology, TUM School of Life Sciences, Technical University Munich, Freising, Germany.
- ZIEL Institute for Food & Health, Technical University Munich, Freising, Germany.
| |
Collapse
|
15
|
Tang VM, Aaronson S, Abdelghani M, Baeken C, Barbour T, Brunoni AR, Bulteau S, Carpenter LL, Croarkin PE, Daskalakis ZJ, Fitzgerald PB, Kozel FA, Le Foll B, Mehta UM, Noda Y, Padberg F, Plewnia C, Su H, van Eijndhoven P, van Exel E, van Oostrom I, Vila-Rodriguez F, Voineskos D, Wilson S, Blumberger DM. Assessment and Management of Concurrent Substance Use in Patients Receiving Repetitive Transcranial Magnetic Stimulation for Depressive, Obsessive-Compulsive, Psychotic, and Trauma-Related Disorders: A Delphi Consensus Study and Guideline. Am J Psychiatry 2025; 182:438-451. [PMID: 40103354 DOI: 10.1176/appi.ajp.20240403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/20/2025]
Abstract
OBJECTIVE Limited data are available to inform clinicians on how to manage concurrent substance use in the context of repetitive transcranial magnetic stimulation (rTMS) for the treatment of depressive, obsessive-compulsive, psychotic, or trauma-related disorders. The authors convened an international panel of 24 rTMS experts, representative of different geographic regions and subspecialities, and created a consensus guideline for clinicians and researchers on approaches to concurrent substance use in patients receiving rTMS as treatment for primary psychiatric disorders. METHODS A Delphi method survey and expert opinion elicited over consecutive rounds of surveys were used, with feedback and discussion after each round. Recommendation statements were established upon very high (≥80%) agreement. RESULTS Three rounds of surveys and feedback were sufficient to reach a consensus for most topics; where consensus could not be reached, the panel discussed limitations in the current evidence base. Informed by a synthesis of the literature and practice-based evidence, the expert panel provides several consensus recommendations on the topics of screening, monitoring, risk assessment, and mitigation associated with various degrees of substance use, and specific considerations for alcohol, cannabis, stimulants, and opioids. Instead of excluding all people who use substances, a nuanced approach should be taken based on an assessment of risk factors for clinical instability and severity of use. The most important safety risk with substance use is the presence of intoxication or withdrawal states, with the most data supporting seizure risk in unstable alcohol or nonmedical stimulant use. Although there is no evidence of reduced rTMS efficacy for a psychiatric disorder in the presence of concurrent substance use, the lack of data in this area warrants caution. CONCLUSIONS These recommendations can be readily implemented clinically and provide a framework for future research. In patients receiving rTMS for a primary psychiatric disorder, assessment and management of co-occurring substance use is complex, requiring greater attention, standardization, and further study.
Collapse
Affiliation(s)
- Victor M Tang
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Scott Aaronson
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Mohamed Abdelghani
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Chris Baeken
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Tracy Barbour
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - André R Brunoni
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Samuel Bulteau
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Linda L Carpenter
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Paul E Croarkin
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Zafiris J Daskalakis
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Paul B Fitzgerald
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - F Andrew Kozel
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Bernard Le Foll
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Urvakhsh Meherwan Mehta
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Yoshihiro Noda
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Frank Padberg
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Christian Plewnia
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Hang Su
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Philip van Eijndhoven
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Eric van Exel
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Iris van Oostrom
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Fidel Vila-Rodriguez
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Daphne Voineskos
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Saydra Wilson
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| | - Daniel M Blumberger
- Temerty Faculty of Medicine, University of Toronto, Toronto (Tang, Le Foll, Voineskos, Blumberger), and the Centre for Addiction and Mental Health, Toronto (Tang, Le Foll, Voineskos, Blumberger); Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, and Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Aaronson); Camden and Islington NHS Foundation Trust, London (Abdelghani); Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University, Ghent, Belgium (Baeken); Department of Psychiatry, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels (Baeken); Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands (Baeken); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (Barbour); Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (Brunoni); CHU Nantes Department of Addictology and Psychiatry, U1246 SPHERE INSERM, Nantes University, Nantes, France (Bulteau); Butler Hospital, Department of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Providence, RI (Carpenter); Mayo Clinic College of Medicine and Science, Rochester, MN (Croarkin); Department of Psychiatry, UC San Diego Health, La Jolla (Daskalakis); School of Medicine and Psychology, Australian National University, Canberra (Fitzgerald); FSU Neuromodulation, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee (Kozel); Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario (Le Foll); Department of Psychiatry, National Institute of Mental Health and Neurosciences, and National Institute of Advanced Studies, Bangalore, India (Mehta); Department of Neuropsychiatry, Keio University School of Medicine, Tokyo (Noda); Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich (Padberg); German Center for Mental Health, Tübingen (Padberg, Plewnia); Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany (Plewnia); Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai (Su); Department of Psychiatry, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (van Eijndhoven); Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam (van Exel); Old Age Psychiatry, GGZinGeest, Amsterdam (van Exel); Amsterdam Neuroscience, Amsterdam (van Exel); Neurocare Clinics, Nijmegen, the Netherlands (van Oostrom); Spanish Consortium of Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, and Health Technology Assessment in Primary Care and Mental Health Research Group (PRISMA), Barcelona (Vila-Rodriguez); School of Biomedical Engineering, University of British Columbia, Vancouver (Vila-Rodriguez); Poul Hansen Family Centre for Depression, Toronto Western Hospital, UHN and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto (Voineskos); Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto (Voineskos, Blumberger); Department of Psychiatry and Behavioral Sciences, University of Minnesota-Twin Cities, Minneapolis (Wilson)
| |
Collapse
|
16
|
de Oliveira Ruiz PB, Gouveia JL, de Oliveira Ruiz PB, de Souza Menezes JD, da Silva MQ, dos Santos ER, de Abreu Lima AR, Brienze VMS, André JC, Ribeiro RDCHM. Urgent surgical patient classification: Development and validation of a novel instrument using the Delphi approach. JOURNAL OF EDUCATION AND HEALTH PROMOTION 2025; 14:177. [PMID: 40400578 PMCID: PMC12094470 DOI: 10.4103/jehp.jehp_1276_24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/12/2024] [Accepted: 12/09/2024] [Indexed: 05/23/2025]
Abstract
BACKGROUND The lack of a triage system for urgent surgical patients leads to non-standardized decision-making. Developing an instrument to objectively identify the complexity of care required for each case is challenging. The aim of this report is to develop and validate an urgent surgical patient classification instrument using the Delphi technique. MATERIALS AND METHODS The study was conducted in several stages: (1) definition of the construct; (2) item elaboration; (3) expert analysis; (4) item selection; (5) pretest. In the first study, scale items were designed and content validity was confirmed. In the second study, the factorial structure was analyzed. In the third study, alternative measurement models were tested. In the fourth study, criterion validity was analyzed. RESULTS Experts validated 14 items (31.81%) from Domain 1 with 75% agreement and specific items from Domain 2 with 100% agreement. Factor analysis indicated a two-factor solution explaining 58.4% of the variance. The bifactor model presented the best fit (χ2/df = 1.51; CFI = 0.95; TLI = 0.94; RMSEA = 0.051; SRMR = 0.043). Factors showed excellent internal consistency (α > 0.88; CR > 0.90; ω > 0.92). CONCLUSION This pioneering study developed and validated the content of the first specific instrument for classifying urgent surgical patients regarding their priority for care. The instrument was deemed valid in terms of content, based on expert consensus. Further studies are recommended to evaluate its practical application and perform additional psychometric measures. This instrument has the potential to enhance the organization of emergency services and operating theaters, promoting patient safety and efficient resource management in healthcare institutions. Its implementation should align with current health guidelines and policies to optimize the triage and prioritization process for urgent surgical patients.
Collapse
|
17
|
Pérez LR, Rodríguez MR, Ortega RV, Alonso SS, Valero TC, Isus PM, Romero LGL. Use of the Delphi method as an instrument of community participation in health needs assessment. J Public Health Policy 2025:10.1057/s41271-025-00559-9. [PMID: 40301566 DOI: 10.1057/s41271-025-00559-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/16/2025] [Indexed: 05/01/2025]
Abstract
We conducted a comprehensive analysis of the usefulness of the Delphi technique for facilitating community participation in local health needs assessments within the Andalusian Local Health Action Network, Spain. We developed an ad hoc online questionnaire based on the Social Determinants of Health model and applied it to a panel of experts in two municipalities in the province of Seville (Andalusia, Spain) between May and June 2021. Our results reflected good panelist participation. The questionnaire successfully enabled the prioritization of both new and original items, some of which were incorporated into local health policies. We concluded that the Delphi method was effective for facilitating participation in local health needs assessments offering a replicable, cost-effective approach that accelerated local policy development and supported the implementation of Health in All Policies within local government.
Collapse
Affiliation(s)
- Luna Rodríguez Pérez
- Local Health Action Network of the Province of Seville, Disease Prevention, Health Promotion and Surveillance Unit, Health District of Seville, Seville, Spain
| | - Manuel Rodríguez Rodríguez
- QuirónSalud Sagrado Corazón Medical Center, Sistema Nacional de Salud (National Healthcare Network), Tomares, Seville, Spain
| | - Rosario Vigo Ortega
- Research Unit, Aljarafe-North Seville Health District, Servicio Andaluz de Salud, Calle Clara Jaime Melero, 2-4, 41008, Seville, Spain.
| | - Silvia Sicre Alonso
- Disease Prevention, Health Promotion and Surveillance Unit, Aljarafe-North Seville Health District, Servicio Andaluz de Salud, Mairena del Aljarafe, Seville, Spain
| | - Tránsito Cebrián Valero
- Local Health Action Network Section, Disease Prevention, Health Promotion and Surveillance Unit, Aljarafe-North Seville Health District, Servicio Andaluz de Salud, Mairena del Aljarafe, Seville, Spain
| | - Pilar Mentuy Isus
- Local Health Action Network Section, Disease Prevention, Health Promotion and Surveillance Unit, Aljarafe-North Seville Health District, Servicio Andaluz de Salud, Mairena del Aljarafe, Seville, Spain
| | - Luis Gabriel Luque Romero
- Research Unit, Aljarafe-North Seville Health District, Servicio Andaluz de Salud, Seville, Spain
- Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Seville, Seville, Spain
- Institute of Biomedicine of Seville (IBiS), Seville, Spain
| |
Collapse
|
18
|
Méndez Lizárraga CA, Armas-González R, Loyola S, Bruno A, Pando-Robles V, Fernández-Niño JA, Muñoz RF, Coloma J, Lescano AG, Bravo-García E, García PJ, Garza J, Pardo E, Welty S, Reid MJA, Sepúlveda J. Pandemic preparedness and response priorities in Latin America: A regional Delphi consensus. Public Health 2025:105602. [PMID: 40288949 DOI: 10.1016/j.puhe.2025.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2024] [Revised: 12/31/2024] [Accepted: 01/07/2025] [Indexed: 04/29/2025]
Abstract
OBJECTIVE The Independent Panel for Pandemic Preparedness and Response issued a series of recommendations for future pandemic preparedness and response. Latin America's COVID-19-related deaths represented 25 % of the global demises, despite harboring less than 8 % of the world's population. As little data exists to support whether the Panel's recommendations reflect public health professionals' priorities in the region the study aimed to define these priorities utilizing a Delphi study. STUDY DESIGN A consensus-building modified Delphi technique. METHODS For the first two rounds, participants were asked to rank a list of topics across seven domains on a 4-point Likert scale. Topics voted by at least 75 % of participants in either round as very important were included in the final round. Participants ranked the topics from each of the seven domains in numeric order to define top priorities. RESULTS A total of 115 responses were obtained across three rounds. Most respondents were involved in direct efforts against COVID-19 (75·0-86·%) and a considerable proportion had more than 16 years of public health experience (37·3-50·0 %). The top priority issues were zoonotic disease-pathogen surveillance systems (27·4 points), robust infection and prevention control programs (22·8 points), and indicator and event-based monitoring and reporting systems (22·1 points). CONCLUSIONS Establishing priorities for future pandemics is critical to ensure better health outcomes. The region should strengthen collaboration and enhance its capacities while conducting country-level analysis and defining priorities for future arrangements.
Collapse
Affiliation(s)
- César Arturo Méndez Lizárraga
- Institute for Global Health Sciences, University of California San Francisco, Mission Hall, Box 1224 550 16th Street, Third Floor, San Francisco, CA, 94158, USA; Facultad de Medicina, Universidad Autónoma de Baja California, Humberto Torres Sanginés s/n, Centro Cívico; C.P. 21000. Mexicali, Mexico.
| | - Ruben Armas-González
- Universidad Espíritu Santo, Av. Samborondón 5, Samborondón, 092301, Ecuador; Instituto Interamericano de Cooperación para la Agricultura IICA Representación Ecuador - Proyecto 5CN-1RBT, Av. 12 de octubre y Francisco Salazar, Quito, Ecuador; Instituto Nacional de Investigación en Salud Pública - INSPI, Julián Coronel 905, Guayaquil, 090514, Ecuador
| | - Steev Loyola
- Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru; Unidad de Investigación Molecular, Facultad de Medicina, Universidad de Cartagena, Cartagena de Indias, Colombia
| | - Alfredo Bruno
- Universidad Agraria del Ecuador (UAE) - Instituto Nacional de Investigación en Salud Publica (INSPI), Av. 25 de Julio, Guayaquil, 090104, Ecuador
| | - Victoria Pando-Robles
- Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Av. Universidad 655. Col. Sta. María Ahuacatitlán, Cuernavaca, Morelos, CP62100, Mexico
| | - Julián Alfredo Fernández-Niño
- Departamento de Salud Pública, Universidad del Norte, Kilómetro 5, Vía Puerto Colombia, Barranquilla, Atlántico, Colombia
| | | | - Josefina Coloma
- University of California, Berkeley School of Public Health. Sustainable Sciences Institute, 188 LiKa Shing Center Berkeley, CA, 94720, USA
| | - Andrés G Lescano
- Universidad Peruana Cayetano Heredia, School of Public Health and Administration, Emerge, Emerging Diseases and Climate Change Research Unit, Av. Honorio Delgado 430, Urb. Ingenieria, Lima 31, San Martin de Porres, Peru
| | - Enrique Bravo-García
- Departamento de Salud Pública. Facultad de Medicina. UNAM, Circuito Escolar s/n, Edificio "B" sexto piso, Ciudad Universitaria, Delegación Coyoacán, C.P. 04510, Ciudad de México, Mexico
| | - Patricia J García
- School of Public Health. Cayetano Heredia University, Ave Honorio Delgado, 430 SMP, Lima 31, Peru
| | - Juan Garza
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de Mexico, Ciudad Universitaria, Coyoacan, Ciudad de Mexico, 04510, Mexico
| | - Esbeydy Pardo
- Institute for Global Health Sciences, University of California San Francisco, Mission Hall, Box 1224 550 16th Street, Third Floor, San Francisco, CA, 94158, USA
| | - Susie Welty
- Institute for Global Health Sciences, University of California San Francisco, Mission Hall, Box 1224 550 16th Street, Third Floor, San Francisco, CA, 94158, USA
| | - Michael J A Reid
- Institute for Global Health Sciences, University of California San Francisco, Mission Hall, Box 1224 550 16th Street, Third Floor, San Francisco, CA, 94158, USA
| | - Jaime Sepúlveda
- Institute for Global Health Sciences, University of California San Francisco, Mission Hall, Box 1224 550 16th Street, Third Floor, San Francisco, CA, 94158, USA
| |
Collapse
|
19
|
Merolli M, Vallance P, McCreesh K, O'Sullivan C, Ahmed O, Kerry R, Butler-Henderson K, Gray K. Entrustable professional activities for physiotherapists to demonstrate digital health competency: an international delphi study. Physiother Theory Pract 2025:1-14. [PMID: 40277460 DOI: 10.1080/09593985.2025.2495130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2024] [Revised: 04/13/2025] [Accepted: 04/14/2025] [Indexed: 04/26/2025]
Abstract
BACKGROUND The physiotherapy workforce is going through a staggering period of change, amidst an evolving technological landscape. Whilst the profession has cautiously begun to embrace digital physiotherapy practice, there remains a lack of clear, evidence-based standardized guidance regarding tangible activities that demonstrate relevant clinical competence with digital health technologies in practice. OBJECTIVE Establish the world's first international consensus on entrustable professional activities (EPAs) for digital physiotherapy practice. METHODS International Delphi study of experts over three rounds, to establish consensus on digital physiotherapy practice EPAs and associated specifications. RESULTS Fifty-five participants completed the study (which was an 83.3% retention rate from round 1). Participants represented 16 countries. Over 50% were academics, and over 30% were clinicians. The final framework consisted of nine EPAs and 56 specifications for digital physiotherapy practice. The highest percentage rated specification was for "obtaining informed consent" for using digital health. CONCLUSIONS This Delphi study is a seminal international consensus on the core EPAs for digital physiotherapy practice. These EPAs materialize competency. As global attention to digital health continues to increase, our workforce will need to continue to mature in this space. This international consensus will support employers, universities, peak bodies, and individual physiotherapists alike to develop alongside technology. With greater evidence and the establishment of international standards, confidence in the outcomes of digital physiotherapy practice will increase.
Collapse
Affiliation(s)
- M Merolli
- Centre for Health Exercise, and Sports Medicine, Department of Physiotherapy, School of Health Sciences, The University of Melbourne, Melbourne, Australia
- Centre for Digital Transformation of Health, The University of Melbourne, Melbourne, Australia
| | - P Vallance
- Department of Physiotherapy, Podiatry, Prosthetics and Orthotics, La Trobe University, Bundoora, Australia
| | - K McCreesh
- School of Allied Health, University of Limerick, Limerick, Ireland
- Ageing Research Centre, Health Research Institute, University of Limerick, Limerick, Ireland
| | - C O'Sullivan
- School of Health & Human Performance, Dublin City University, Dublin, Ireland
| | - O Ahmed
- Physiotherapy, University Hospitals Dorset NHS Foundation Trust, Poole, UK
- School of Sport, Health and Exercise Science, University of Portsmouth, Portsmouth, UK
| | - R Kerry
- School of Health Sciences, University of Nottingham, Nottingham, UK
| | - K Butler-Henderson
- School of Nursing, Paramedicine, and Healthcare Sciences, Charles Sturt University, Wagga Wagga, Australia
| | - K Gray
- Centre for Digital Transformation of Health, The University of Melbourne, Melbourne, Australia
| |
Collapse
|
20
|
Zhu Y, Ren Y, Ma J, Wan F, Liu F, Du F, Li W, Tian T, Liu X, Li L, Jia Z. Development of a questionnaire to evaluate the management of gestational diabetes mellitus patients among obstetric nurses. Front Public Health 2025; 13:1521673. [PMID: 40337737 PMCID: PMC12055769 DOI: 10.3389/fpubh.2025.1521673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2024] [Accepted: 03/27/2025] [Indexed: 05/09/2025] Open
Abstract
Background The role of obstetric nurses in the management of gestational diabetes mellitus (GDM) is becoming increasingly important, and their management level will directly affect the patient's health education and even the pregnancy outcome. However, there is a lack of tools to measure the competencies of GDM management among obstetric nurses. Methods The questionnaire was developed in two stages: (a) creation of an initial questionnaire based on the definition of competency, literature review, and semi-structured interviews, followed by two rounds of Delphi expert inquiry; (b) evaluation of the questionnaire via piloting study on 30 obstetric nurses and testing of validity and reliability on 239 obstetric nurses. Results A questionnaire containing dimensions of professional knowledge, professional skills, professional competence and personal attitude was developed. Correlation analysis revealed statistically significant correlations (p < 0.01) between each item and the total score, although two items had r-values <0.4, indicating weak correlations, so they were removed. The initial Cronbach's α coefficient of 0.970 indicated that no items needed to be excluded. Five experts evaluated the content validity, yielding an S-CVI/Ave of 0.95 and the I-CVI values range from 0.80 to 1.00, meeting the reference standard. The Cronbach's α coefficients for the four dimensions ranged from 0.793 to 0.928, while the overall Cronbach's α coefficient of the questionnaire was 0.970. The retest reliability was 0.907, and the fold-half reliability was 0.950. The results of the reliability tests all met the measurement requirements of the questionnaire and could be used to evaluate the competency of obstetric nurses in the management of GDM patients. Conclusion This study developed an assessment tool for evaluating the management ability of obstetric nurses for GDM patients, which consists of four dimensions and 35 items. The dimensions and items demonstrate the content of the competence theory, and the questionnaire shows good stability and reliability and validity. Recommendations for practice It is recommended that healthcare institutions integrate this questionnaire into training and evaluation programs for obstetric nurses to improve care quality for GDM patients. Regular use will ensure nurses have the knowledge, skills, and attitudes needed to provide optimal care.
Collapse
Affiliation(s)
- Yongyan Zhu
- Department of Nursing, Henan Vocational College of Tuina, Luoyang, China
- College of Nursing, Henan University of Science and Technology, Luoyang, China
| | - Yumin Ren
- Third Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
| | - Jing Ma
- College of Nursing, Henan University of Science and Technology, Luoyang, China
| | - Feifei Wan
- Department of Nursing, Henan Vocational College of Tuina, Luoyang, China
| | - Feifan Liu
- Department of Nursing, Henan Vocational College of Tuina, Luoyang, China
| | - Fangfang Du
- Department of Nursing, Henan Vocational College of Tuina, Luoyang, China
| | - Weili Li
- Department of Nursing, Henan Vocational College of Tuina, Luoyang, China
| | - Tian Tian
- Department of Nursing, Henan Vocational College of Tuina, Luoyang, China
| | - Xiaoqian Liu
- Department of Nursing, Henan Vocational College of Tuina, Luoyang, China
| | - Lili Li
- First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
| | - Zhumin Jia
- First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
| |
Collapse
|
21
|
Jakstas T, Bucher T, Miller A, Shrewsbury VA, Collins CE. Content validation of the teacher food and nutrition-related health and wellbeing questionnaire, a Delphi study. BMC Public Health 2025; 25:1468. [PMID: 40259288 PMCID: PMC12010570 DOI: 10.1186/s12889-025-22555-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2024] [Accepted: 04/01/2025] [Indexed: 04/23/2025] Open
Abstract
BACKGROUND Schoolteachers' personal health and wellbeing are priority to ensure quality teaching, positive student outcomes and improving teacher retention. With limited-availability of validated tools to measure teacher food and nutrition (FN) as a component of wellbeing, this study aims to evaluate the content validity of the Teacher Food and Nutrition-related health and wellbeing Questionnaire (TFNQ) to fill this gap. METHOD A two-round Delphi was used to refine the questionnaire and establish content validity. Round-one reviewed constructs and lifestyle covariates (LC) for inclusion. Round-two considered construct phrasing, appropriateness of scales and questionnaire order. Descriptive and thematic analyses were conducted. RESULTS Round-one included 23 international experts, with 19 also participating in round-two. After round-one, seven constructs and three LC were removed with two constructs revised into four concise new groupings to refine the TFNQ. In round-two 83% of experts agreed with questionnaire order, and feedback indicated only minor adjustments. The final TFNQ contains 26 FN and wellbeing constructs and three LC. CONCLUSION This Delphi study established content validity of the TFNQ to appropriately measure key aspects of FN as a component of wellbeing in schoolteachers. Future testing will evaluate the TFNQ construct validity and reliability.
Collapse
Affiliation(s)
- Tammie Jakstas
- School of Health Sciences, College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, 2308, Australia.
- Food and Nutrition Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia.
| | - Tamara Bucher
- Food and Nutrition Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia
- School of Environmental and Life Sciences, College of Engineering, Science and Environment, The University of Newcastle, Callaghan, NSW, 2308, Australia
- School of Health Professions, Bern University of Applied Sciences, Bern, Switzerland
| | - Andrew Miller
- School of Education, College of Human and Social Futures, The University of Newcastle, Callaghan, NSW, 2308, Australia
- Priority Research Centre for Teachers and Teaching, The University of Newcastle, Callaghan, NSW, 2308, Australia
| | - Vanessa A Shrewsbury
- School of Health Sciences, College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, 2308, Australia
- Food and Nutrition Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia
| | - Clare E Collins
- School of Health Sciences, College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, 2308, Australia
- Food and Nutrition Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia
| |
Collapse
|
22
|
Chow JSF, Brunier G, Neumann JL, Lim K, Figueiredo AE. Ten things I wish I knew as a new peritoneal dialysis nurse. Perit Dial Int 2025:8968608251331832. [PMID: 40233157 DOI: 10.1177/08968608251331832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/17/2025] Open
Abstract
A nurse new to home peritoneal dialysis (PD) undoubtedly has to learn all the steps for continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) procedures, along with basics such as hand hygiene, ordering supplies, disposing of supplies, recognizing signs and symptoms of peritonitis. However, it is not always clear what else the new PD nurse needs to know in order to successfully teach a patient all that a patient (and care partner) starting home PD training need to know, as well as to support that patient overtime once the patient is performing PD at home. To answer this question, using a modified Delphi technique, members of the International Society for Peritoneal Dialysis (ISPD) Nursing and Allied Health Professional Committee identified the top 10 practice advice (tips) these nurse members thought all new home PD nurses should know and be aware of. For each tip, we justified the importance of the tip and how it could be implemented. The 10 tips were quite varied and highlighted both the breadth and the depth of knowledge a new PD nurse needs to acquire over and above basic knowledge and skills such as performing CAPD and APD and recognizing signs and symptoms of peritonitis. The members of the ISPD Nursing and Allied Health Professional Committee who compiled this list of the top 10 tips, believe that through understanding the importance, justification, and implementation of each of these tips, the nurse new to a home PD program can, in turn, appreciate more how to individualize home PD training sessions, improve the quality of life for patients on PD, as well as extend the patients' time on PD.
Collapse
Affiliation(s)
- Josephine Sau Fan Chow
- South Western Sydney Nursing & Midwifery Research Alliance, South Western Sydney Local Health District, Liverpool, New South Wales, Australia
- South Western Sydney Nursing & Midwifery Research Alliance, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia
- Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
- NICM Health Research Institute, Western Sydney University, Sydney, New South Wales, Australia
- Faculty of Nursing, University of Tasmania, Hobart, Tasmania, Australia
| | | | | | - Kelly Lim
- Renal Department, Tan Tock Seng Hospital, Singapore
| | - Ana Elizabeth Figueiredo
- Curso de Enfermagem, Escola de Ciência da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil
| |
Collapse
|
23
|
Ferguson JJ, Clarke ED, Stanford J, Gómez-Martín M, Jakstas T, Collins CE. Diet Item Details: Reporting Checklist for Feeding Studies Measuring the Dietary Metabolome (DID-METAB Checklist)-Explanation and Elaboration Report on the Development of the Checklist by the DID-METAB Delphi Working Group. Adv Nutr 2025; 16:100420. [PMID: 40239809 DOI: 10.1016/j.advnut.2025.100420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2025] [Revised: 03/19/2025] [Accepted: 03/30/2025] [Indexed: 04/18/2025] Open
Abstract
Metabolomics is a postgenomic, systems-based discipline offering valuable applications in nutrition research, including the use of objective biomarkers to characterize dietary intake and metabolic responses more accurately. A scoping review identified the need for reporting guidance on dietary information in the form of a checklist to ensure reproducibility of human feeding studies that are measuring the diet-related metabolome. In this study, we aimed to gain consensus on a core outcome set pertaining to diet-related item details (DIDs) and recommendations for reporting DIDs to inform development of a reporting checklist. The goal of this checklist is to guide researchers on the minimum level of content and detail required for reporting dietary information in human feeding studies measuring the metabolome. A 2-stage online Delphi process encompassing 5 survey rounds with international experts in clinical trial design, feeding study intervention implementation, metabolomics, and/or human biospecimen analyses was conducted. A core outcome set encompassing 29 DIDs and accompanying recommendations was developed across 5 domains: dietary intervention-modeling (8 DIDs), dietary intervention-implementation (3 DIDs), dietary assessment (9 DIDs), adherence and compliance monitoring (4 DIDs), and bias (5 DIDs). The reporting guideline (DID-METAB Checklist) was generated and accepted by the international expert working group in the final survey round. All experts agreed that relevant journals should include the checklist as a suggested reporting tool for relevant studies and/or used alongside existing reporting tools. This report provides examples, explanations and elaboration for each recommendation including examples from published literature and references. The DID-METAB Checklist will be a key tool to advance the standardized reporting for feeding studies assessing the metabolome. Implementation of this tool will enable the ability to better interpret data and ensure global utility of results for furthering the advancement of metabolomics in nutrition research and future precision and personalized nutrition strategies.
Collapse
Affiliation(s)
- Jessica Ja Ferguson
- School of Health Sciences, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, New South Wales, Australia; Food and Nutrition Research Program, Hunter Medical Research Institute, New Castle, New South Wales, Australia
| | - Erin D Clarke
- School of Health Sciences, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, New South Wales, Australia; Food and Nutrition Research Program, Hunter Medical Research Institute, New Castle, New South Wales, Australia
| | - Jordan Stanford
- School of Health Sciences, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, New South Wales, Australia; Food and Nutrition Research Program, Hunter Medical Research Institute, New Castle, New South Wales, Australia
| | - María Gómez-Martín
- School of Health Sciences, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, New South Wales, Australia; Food and Nutrition Research Program, Hunter Medical Research Institute, New Castle, New South Wales, Australia
| | - Tammie Jakstas
- School of Health Sciences, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, New South Wales, Australia; Food and Nutrition Research Program, Hunter Medical Research Institute, New Castle, New South Wales, Australia
| | - Clare E Collins
- School of Health Sciences, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, New South Wales, Australia; Food and Nutrition Research Program, Hunter Medical Research Institute, New Castle, New South Wales, Australia.
| |
Collapse
|
24
|
Mercante A, Nardocci N, Fernández-Alvarez E, Lumsden DE, Hauer J, Bernadá M, Drake R, Kreicbergs U, Palomo-Carrión R, Gemma M, Coubes P, Fasano A, Lin JP, Benini F. Towards new perspectives: International consensus guidance on dystonia in pediatric palliative care. Eur J Paediatr Neurol 2025; 56:24-37. [PMID: 40267817 DOI: 10.1016/j.ejpn.2025.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/01/2024] [Revised: 03/23/2025] [Accepted: 04/03/2025] [Indexed: 04/25/2025]
Abstract
BACKGROUND Pediatric dystonias are associated with a broad spectrum of etiologies, resulting in a heterogeneous patient population in whom clinical presentation, evolution, and therapeutic needs may differ. These neurological symptoms are particularly common in children and adolescents with life-limiting and life-threatening conditions requiring pediatric palliative care (PPC). The impact on the child's quality of life is significant, as is distress for caregivers. Addressing and alleviating dystonia is key to providing good palliative care; however, there is limited evidence. A greater recognition and management of dystonia in this setting is urgently needed to provide appropriate interventions and care. OBJECTIVES To develop a standardized approach to dystonia in PPC. MATERIALS AND METHODS A two-round Delphi process explored the views of experts on the definition, assessment, monitoring, and treatment of dystonia in PPC. Professionals from different backgrounds and disciplines were invited worldwide. The final panel comprised 71 participants who completed a multi-statement online questionnaire. RESULTS Fifty-three items were endorsed, providing expert, consensus-based recommendations. CONCLUSIONS The limited clinical knowledge of childhood dystonia represents a challenge, especially in children with palliative care needs. This study is a first international consensus on dystonia in PPC and offers novel approaches to improving the dystonia-related burden and advancing clinical practice in this vulnerable population.
Collapse
Affiliation(s)
- Anna Mercante
- Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
| | - Nardo Nardocci
- Dipartimento di Neuroscienze Pediatriche Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milano, Italy
| | | | - Daniel E Lumsden
- Complex Motor Disorder Service, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK; Research Department of Early Life Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK
| | - Julie Hauer
- Division of General Pediatrics, Boston Children's Hospital, Boston, MA, USA
| | - Mercedes Bernadá
- Pereira Rossell Hospital Center and Asociación Española Pediatric Palliative Care Units, Montevideo, Uruguay
| | - Ross Drake
- Queensland Paediatric Palliative Care Service and Queensland Interdisciplinary Paediatric Persistent Pain Service, Queensland Children's Hospital, South Brisbane, Australia
| | - Ulrika Kreicbergs
- The Department of Women's and Children's Health, Paediatric Oncology and Haematology, Karolinska Institutet, Karolinska University Hospital, Astrid Lindgren Children's Hospital, Childhood Cancer Research Unit, Stockholm, Sweden; Department of Population, Policy and Practice, Great Ormond Street Institute of Child Health, University College London, London, UK
| | - Rocío Palomo-Carrión
- Nursing, Physiotherapy and Occupational Therapy Department. Faculty of Physiotherapy and Nursing, University of Castilla-La Mancha, Toledo, Spain
| | - Marco Gemma
- Neuroanesthesia and Intensive Care Unit Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
| | - Philippe Coubes
- Unité Pathologies Cérébrales Résistantes et Unité de Recherche sur ses Comportements et Mouvements Anormaux (URCMA), Département de Neurochirurgie, CHU Montpellier, France
| | - Alfonso Fasano
- Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN. Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute, Toronto, Ontario, Canada
| | - Jean-Pierre Lin
- Complex Motor Disorder Service, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK; Children's Neurosciences, Department of Women and Children, Faculty of Life Sciences and Medicine, King's College London, London, UK
| | - Franca Benini
- Pediatric Palliative Care, Pain Service, Department of Women's and Children's Health, University Hospital of Padua, Padua, Italy
| |
Collapse
|
25
|
Chen Z, Huang S, Hao F, Chen L, Ren W, Cai W. Development of a Maternal Health Care Exercise and Pelvic Abdominal Rehabilitation Curriculum for Obstetric Medical Professionals Using a Modified Delphi Process. Int Urogynecol J 2025:10.1007/s00192-025-06125-x. [PMID: 40202529 DOI: 10.1007/s00192-025-06125-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2024] [Accepted: 03/08/2025] [Indexed: 04/10/2025]
Abstract
INTRODUCTION AND HYPOTHESIS The purpose of this study was to develop a maternal health care exercise and pelvic abdominal rehabilitation curriculum for obstetric medical professionals. Maternal health care exercise and pelvic abdominal rehabilitation can effectively prevent and alleviate pelvic-floor-rehabilitation problems in pregnant women and improve their quality of life. However, there is a lack of standardized courses for training obstetric medical professionals. METHODS This study used the Delphi method to design two rounds of expert consultation. A group of 17 specialists from the fields of gynecology, obstetrics, and rehabilitation, who are involved in clinical teaching and management, participated in the study. Data were collected between October and December 2023. RESULTS The effective recovery rates of the two rounds of questionnaires were 85.0% and 94.1%. The expert-authority coefficients were 0.90 and 0.88. The Kendall coordination coefficient was 0.35-0.41. The average importance score for each index ranged from 3.25 to 4.94. The coefficient of variation for each index ranged from 0.07 0.20. Based on the curricular topics, we constructed four first-level indicators, 16 second-level indicators, and 58 third-level indicators of exercise and pelvic and abdominal rehabilitation for obstetric medical professionals. CONCLUSION The training curriculum provides obstetric medical professionals with the basis for obstetric rehabilitation. The training system is clear and coherent, and the content is clear and comprehensive, which enriches global obstetrical rehabilitation education resources. It is helpful to guide and educate on maternal obstetric rehabilitation to improve the quality of life of the women.
Collapse
Affiliation(s)
- Zhaoying Chen
- Department of Nursing, Shenzhen Hospital of Southern Medical University, Room 815, Administrative Building, Xinhu Road 1333, Baoan Area, Shenzhen, Guangdong Province, China
- School of Nursing, Southern Medical University, Guangzhou, Guangdong Province, China
| | - Shijie Huang
- Department of Nursing, Shenzhen Hospital of Southern Medical University, Room 815, Administrative Building, Xinhu Road 1333, Baoan Area, Shenzhen, Guangdong Province, China
- School of Nursing, Southern Medical University, Guangzhou, Guangdong Province, China
| | - Fengming Hao
- School of Nursing, Shanxi Technology and Business University, Taiyuan, Shanxi, China
| | - Ling Chen
- Department of Nursing, Shenzhen Hospital of Southern Medical University, Room 815, Administrative Building, Xinhu Road 1333, Baoan Area, Shenzhen, Guangdong Province, China
- School of Nursing, Southern Medical University, Guangzhou, Guangdong Province, China
| | - Wei Ren
- Department of Nursing, Shenzhen Hospital of Southern Medical University, Room 815, Administrative Building, Xinhu Road 1333, Baoan Area, Shenzhen, Guangdong Province, China
- School of Nursing, Southern Medical University, Guangzhou, Guangdong Province, China
| | - Wenzhi Cai
- Department of Nursing, Shenzhen Hospital of Southern Medical University, Room 815, Administrative Building, Xinhu Road 1333, Baoan Area, Shenzhen, Guangdong Province, China.
- School of Nursing, Southern Medical University, Guangzhou, Guangdong Province, China.
| |
Collapse
|
26
|
Alaze A, Finne E, Razum O, Miani C. A questionnaire for a conceptual framework and interdisciplinary public health research using the Delphi technique-development and validation. Front Public Health 2025; 13:1436569. [PMID: 40236321 PMCID: PMC11996889 DOI: 10.3389/fpubh.2025.1436569] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2024] [Accepted: 02/19/2025] [Indexed: 04/17/2025] Open
Abstract
Background The Delphi technique has become established in public health research, yet there is a lack of methodological standards in questionnaire development. We here demonstrate how the Delphi technique can be used in an interdisciplinary public health topic for framework development, and we highlight methodological challenges and possible solutions. Methods We developed the questionnaire through a comprehensive literature review and the generation of an item pool based on the rules of item construction. We used cognitive interviews, a Delphi experts assessment and group discussions to refine the questionnaire and to ensure content validity. Finally, we carried out a pre-test of the online questionnaire. Results The questionnaire consists of three main sections, namely gender (norms), the social environment and the mental health of adolescents, and another section on characteristics of the panelists. It comprises a total of 32 questions and includes rating and ranking questions, content-related and comment questions, open and closed questions as well as questions on personal characteristics and evaluation questions. Conclusion To address challenges in the development process, interdisciplinary researchers need to be involved. They should consider certain aspects of the development process to provide more structure and clarity, such as comprehensively preprocessing the content, and disentangling and simplifying the theoretical concepts. They should consider a rigorous approach to develop more complex frameworks for interdisciplinary public health topics. Future research should focus on developing methodological guidelines and testing their applicability for different objectives of the Delphi technique (e.g., framework development).
Collapse
Affiliation(s)
- Anita Alaze
- Department of Epidemiology and International Public Health, School of Public Health, Bielefeld University, Bielefeld, Germany
| | | | | | | |
Collapse
|
27
|
Trinquand A, Leveson J, Barbosa AL, Gameiro P, Vesterinen T, Lammens T, Drost T, Moorman AV, de Haas V, Bond J, Boer JM. ALLTogether recommendations for biobanking samples from patients with acute lymphoblastic leukaemia: a modified Delphi study. Br J Cancer 2025; 132:493-501. [PMID: 39987377 PMCID: PMC11920285 DOI: 10.1038/s41416-025-02958-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2024] [Revised: 11/28/2024] [Accepted: 02/06/2025] [Indexed: 02/24/2025] Open
Abstract
Acute lymphoblastic leukaemia (ALL) is a rare and heterogeneous disease. The ALLTogether consortium has implemented a treatment protocol to improve outcome and reduce treatment-related toxicity across much of Europe. The consortium provides the opportunity to design translational research on patient material stored in national biobanks. However, there are currently no standardized guidelines for the types of material, processing, and storage for leukaemia biobanking. To address this gap, we conducted a modified Delphi survey among 53 experts in different roles related to leukaemia. The first round consisted of 63 statements asking for level of agreement. The second round refined some to reach consensus, using yes-no and multiple-option answers. Key recommendations include cryopreservation of cells from diagnosis, post-induction, post-consolidation, and relapse, with at least two aliquots of plasma and serum, and cerebrospinal fluid from diagnosis, day15, and post-induction. It was advised to distribute cells across multiple vials for various research projects, and to collect data on sample processing, cell viability, and blast percentage. Quality monitoring and user feedback were strongly recommended. The Delphi survey resulted in strong recommendations that can be used by national biobanks to harmonize storage of samples from patients with ALL and ensure high-quality cryopreserved cells for research studies.
Collapse
Affiliation(s)
- Amélie Trinquand
- National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland
| | | | - Ana Lúcia Barbosa
- Department of Haematology, Instituto Português de Oncologia, Lisbon, Portugal
| | - Paula Gameiro
- Department of Haematology, Instituto Português de Oncologia, Lisbon, Portugal
| | - Tiina Vesterinen
- Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
| | - Tim Lammens
- Department of Internal Medicine and Pediatrics, Ghent University, 9000, Ghent, Belgium
- Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, 9000, Ghent, Belgium
- Cancer Research Institute Ghent, 9000, Ghent, Belgium
| | - Thomas Drost
- ALLTogether Patient and Public Involvement in Research (PPI) representative, Utrecht, The Netherlands
| | - Anthony V Moorman
- Leukaemia Research Cytogenetics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
| | - Valérie de Haas
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
| | - Jonathan Bond
- National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland
- Systems Biology Ireland, School of Medicine, University College Dublin, Dublin, Ireland
| | - Judith M Boer
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
| |
Collapse
|
28
|
Zanjir M, Cardoso E, Harman NL, Khansari A, Jafarzadeh H, Malkhassian G, Sabeti M, Aminoshariae A, Kishen A, Sale JEM, Shah PS, Azarpazhooh A. Development of a Core Outcome Set in Endodontics (COS-ENDO): Part 5 - COS-ENDO for Studies of Apexification and Regenerative Endodontics in Permanent Teeth. J Endod 2025; 51:457-472. [PMID: 39892664 DOI: 10.1016/j.joen.2025.01.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2024] [Accepted: 01/14/2025] [Indexed: 02/04/2025]
Abstract
INTRODUCTION Methodological heterogeneity and reporting bias complicate interpreting endodontic outcomes. Supported by the American Association of Endodontists and its Foundation, this study developed the Core Outcome Set in Endodontics (COS-ENDO) to standardize reporting for studies of Nonsurgical Root Canal Treatment/Retreatment, Surgical Endodontics, Vital Pulp Therapy, Apexification, and Regenerative Endodontics. This article, the last in a 5-part series, focuses on COS-ENDO for Apexification and Regenerative Endodontics, while other parts address the remaining treatments. METHODS Outcomes were identified through scoping reviews and a web-based survey of American Association of Endodontists practicing members. In a 2-round Delphi survey, clinicians, patients, and researchers rated outcomes on a 9-point scale. Ratings were assessed against consensus criteria, and a virtual meeting finalized COS-ENDO. RESULTS Of the 97 invited participants to Round 1, 77 registered, and 73 (24 Academicians/Researchers, 26 Clinicians, and 23 Patients or their parents/caregivers) assessed 51 outcomes, with 18 excluded. The remaining outcomes-7 achieving consensus for inclusion and 26 lacking consensus-advanced to Round 2 for re-rating by 70 participants. This resulted in 14 outcome achieving consensus for inclusion, and 19 lacking consensus. In the final meeting, 16 participants finalized the COS-ENDO for Apexification and Regenerative Endodontics, including Tooth survival, Pain, Signs of infection, Radiographic evidence of periradicular healing, Continued root development, Success, Functional tooth, Need for further intervention, and Adverse events/Complications. CONCLUSION COS-ENDO is an important step in standardizing outcome reporting in endodontics, ensuring consistent reporting and enhancing research utility. Further efforts are needed to establish optimal measurement methods.
Collapse
Affiliation(s)
- Maryam Zanjir
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada
| | - Elaine Cardoso
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - Nicola L Harman
- Department of Health Data Science, University of Liverpool, Liverpool, United Kingdom
| | - Ava Khansari
- Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
| | - Hamid Jafarzadeh
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Endodontics, School of Dentistry, West Virginia University, Morgantown, West Virginia
| | - Gevik Malkhassian
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada
| | - Mike Sabeti
- School of Dentistry, University of California San Francisco, San Francisco, California
| | - Anita Aminoshariae
- Department of Endodontics, School of Dental Medicine, Case Western Reserve University, Cleveland, Ohio
| | - Anil Kishen
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada; The Kishen Lab, Dental Research Institute, University of Toronto, Toronto, Ontario, Canada
| | - Joanna E M Sale
- St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Faculty of Medicine, Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - Prakesh S Shah
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Faculty of Medicine, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - Amir Azarpazhooh
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
| |
Collapse
|
29
|
Zanjir M, Cardoso E, Harman NL, Khansari A, Jafarzadeh H, Malkhassian G, Sabeti M, Aminoshariae A, Kishen A, Sale JEM, Shah PS, Azarpazhooh A. Development of a Core Outcome Set in Endodontics (COS-ENDO): Part 3 - COS-ENDO for Studies of Surgical Endodontics in Permanent Teeth. J Endod 2025; 51:427-441. [PMID: 39892661 DOI: 10.1016/j.joen.2025.01.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2024] [Accepted: 01/14/2025] [Indexed: 02/04/2025]
Abstract
INTRODUCTION Methodological heterogeneity and reporting bias complicate interpreting endodontic outcomes. Supported by the American Association of Endodontists and its Foundation, this study developed the Core Outcome Set in Endodontics (COS-ENDO) to standardize reporting for studies of nonsurgical root canal treatment/retreatment, surgical endodontics, vital pulp therapy, apexification, and regenerative endodontics. This article, part 3 of a 5-part series, focuses on COS-ENDO for surgical endodontics, while other parts address the remaining treatments. METHODS Outcomes were identified through a scoping review, a qualitative study with patients, and a web-based survey of American Association of Endodontists practicing members. In a 2-round Delphi survey, clinicians, patients, and researchers rated outcomes on a 9-point scale. Ratings were assessed against consensus criteria, and a virtual meeting finalized COS-ENDO. RESULTS Of the 97 invited participants to round 1, 77 registered, and 73 (24 academicians/researchers, 26 clinicians, and 23 patients or their parents/caregivers) assessed 46 outcomes, with 17 excluded. The remaining outcomes-7 achieving consensus for inclusion and 22 lacking consensus-advanced to round 2 for rerating by 70 participants. This resulted in 1 outcome achieving consensus for exclusion, 10 for inclusion, and 18 lacking consensus. In the final meeting, 16 participants finalized the COS-ENDO for surgical endodontics, including Tooth survival, Pain, Signs of infection, Radiographic evidence of periradicular healing, Success, Functional tooth, Need for further intervention, and Adverse events/Complications. CONCLUSIONS COS-ENDO is an important step in standardizing outcome reporting in endodontics, ensuring consistent reporting and enhancing research utility. Further efforts are needed to establish optimal measurement methods.
Collapse
Affiliation(s)
- Maryam Zanjir
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada
| | - Elaine Cardoso
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - Nicola L Harman
- Department of Health Data Science, University of Liverpool, Liverpool, UK
| | - Ava Khansari
- Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
| | - Hamid Jafarzadeh
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Endodontics, School of Dentistry, West Virginia University, Morgantown, West Virginia
| | - Gevik Malkhassian
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada
| | - Mike Sabeti
- School of Dentistry, University of California San Francisco, San Francisco, California
| | - Anita Aminoshariae
- Department of Endodontics, School of Dental Medicine, Case Western Reserve University, Cleveland, Ohio
| | - Anil Kishen
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada; The Kishen Lab, Dental Research Institute, University of Toronto, Toronto, Ontario, Canada
| | - Joanna E M Sale
- St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - Prakesh S Shah
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - Amir Azarpazhooh
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
| |
Collapse
|
30
|
Zanjir M, Cardoso E, Harman NL, Khansari A, Jafarzadeh H, Malkhassian G, Sabeti M, Aminoshariae A, Kishen A, Sale JEM, Shah PS, Azarpazhooh A. Development of a Core Outcome Set in Endodontics (COS-ENDO): Part 2 - COS-ENDO for Studies of Nonsurgical Root Canal Treatment and Retreatment in Permanent Teeth. J Endod 2025; 51:412-426. [PMID: 39892663 DOI: 10.1016/j.joen.2025.01.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2024] [Accepted: 01/14/2025] [Indexed: 02/04/2025]
Abstract
INTRODUCTION Methodological heterogeneity and reporting bias complicate interpreting endodontic outcomes. Supported by the American Association of Endodontists and its Foundation, this study developed the Core Outcome Set in Endodontics (COS-ENDO) to standardize reporting for studies of Nonsurgical Root Canal Treatment/Retreatment, Surgical Endodontics, Vital Pulp Therapy, Apexification, and Regenerative Endodontics. This article, Part 2 of a 5-part series, focuses on COS-ENDO for Nonsurgical Root Canal Treatment/Retreatment, while other parts address the remaining treatments. METHODS Outcomes were identified through scoping reviews, a qualitative study with patients, and a web-based survey of American Association of Endodontists practicing members. In a 2-round Delphi survey, clinicians, patients, and researchers rated outcomes on a 9-point scale. Ratings were assessed against consensus criteria, and a virtual meeting finalized COS-ENDO. RESULTS Of the 97 invited participants to Round 1, 77 registered, and 73 (24 Academicians/Researchers, 26 Clinicians, and 23 Patients (or their parents/caregivers)) assessed 39 outcomes, with 18 excluded. The remaining outcomes-7 achieving consensus for inclusion and 14 lacking consensus-advanced to Round 2 for re-rating by 70 participants. This resulted in 9 outcomes achieving consensus for inclusion, and 12 lacking consensus. In the final meeting, 16 participants finalized the COS-ENDO for Nonsurgical Root Canal Treatment/Retreatment, including Tooth survival, Pain, Signs of infection, Radiographic evidence of periradicular healing, Success, Functional tooth, Need for further intervention, and Adverse events/Complications. CONCLUSIONS COS-ENDO is an important step in standardizing outcome reporting in endodontics, ensuring consistent reporting and enhancing research utility. Further efforts are needed to establish optimal measurement methods.
Collapse
Affiliation(s)
- Maryam Zanjir
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada
| | - Elaine Cardoso
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - Nicola L Harman
- Department of Health Data Science, University of Liverpool, Liverpool, UK
| | - Ava Khansari
- Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
| | - Hamid Jafarzadeh
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Endodontics, School of Dentistry, West Virginia University, Morgantown, West Virginia
| | - Gevik Malkhassian
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada
| | - Mike Sabeti
- School of Dentistry, University of California San Francisco, San Francisco, California
| | - Anita Aminoshariae
- Department of Endodontics, School of Dental Medicine, Case Western Reserve University, Cleveland, Ohio
| | - Anil Kishen
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada; The Kishen Lab, Dental Research Institute, University of Toronto, Toronto, Ontario, Canada
| | - Joanna E M Sale
- St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - Prakesh S Shah
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - Amir Azarpazhooh
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
| |
Collapse
|
31
|
Azarpazhooh A, Zanjir M, Cardoso E, Harman NL, Khansari A, Jafarzadeh H, Malkhassian G, Sabeti M, Aminoshariae A, Kishen A, Sale JEM, Shah PS. Development of a Core Outcome Set in Endodontics (COS-ENDO): Part 1 - General Methods for Developing COS-ENDO for Studies of Nonsurgical Root Canal Treatment, Retreatment, Surgical Endodontics, Vital Pulp Therapy, Apexification, and Regenerative Endodontics in Permanent Teeth. J Endod 2025; 51:401-411. [PMID: 39892660 DOI: 10.1016/j.joen.2025.01.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2024] [Accepted: 01/14/2025] [Indexed: 02/04/2025]
Abstract
INTRODUCTION Methodological heterogeneity and reporting bias complicate interpreting endodontic outcomes. Supported by the American Association of Endodontists and its Foundation, this study developed the Core Outcome Set in Endodontics (COS-ENDO) to standardize reporting for studies of nonsurgical root canal treatment/retreatment, surgical endodontics, vital pulp therapy, apexification, and regenerative endodontics. This article, the first in a 5-part series, outlines the methods for developing COS-ENDO, with detailed findings for each treatment presented in subsequent parts. METHODS Outcomes were identified through scoping reviews, a qualitative study with patients, and a web-based survey of American Association of Endodontists practicing members. In a 2-round Delphi survey, clinicians, patients, and researchers rated outcomes on a 9-point scale. Ratings were assessed against consensus criteria, and a virtual meeting finalized COS-ENDO. RESULTS Of the 97 invited participants to round 1, 77 (79%) registered and 73 (95%) completed the survey, including 24 academicians/researchers, 26 clinicians, and 23 patients (or their caregivers/parents). They rated 64 outcomes, totaling 182 occurrences across treatments: 39 for nonsurgical root canal treatment/retreatment, 46 for surgical endodontics, 46 for vital pulp therapy, and 51 for apexification/regenerative endodontics. The outcomes that achieved consensus for inclusion and those lacking consensus (either for inclusion or exclusion) advanced to round 2 for rerating by 70 participants. During the final consensus meeting, 16 participants discussed the outcomes and finalized the COS-ENDO. CONCLUSION COS-ENDO is an important step toward standardizing outcome reporting in endodontics. Its implementation will ensure consistent reporting, enhancing research utility and evidence synthesis. Further efforts are needed to establish optimal measurement methods.
Collapse
Affiliation(s)
- Amir Azarpazhooh
- Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
| | - Maryam Zanjir
- Faculty of Dentistry, University of Toronto, Toronto, ON, Canada
| | - Elaine Cardoso
- Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, ON, Canada
| | - Nicola L Harman
- Department of Health Data Science, University of Liverpool, Liverpool, UK
| | - Ava Khansari
- Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada
| | - Hamid Jafarzadeh
- Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Department of Endodontics, School of Dentistry, West Virginia University, Morgantown, West Virginia
| | | | - Mike Sabeti
- School of Dentistry, University of California San Francisco, San Francisco, California
| | - Anita Aminoshariae
- Department of Endodontics, School of Dental Medicine, Case Western Reserve University, Cleveland, Ohio
| | - Anil Kishen
- Faculty of Dentistry, University of Toronto, Toronto, ON, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, ON, Canada; The Kishen Lab, Dental Research Institute, University of Toronto, Toronto, ON, Canada
| | - Joanna E M Sale
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada; Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
| | - Prakesh S Shah
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Department of Pediatrics, Mount Sinai Hospital, Toronto, ON, Canada
| |
Collapse
|
32
|
Zanjir M, Cardoso E, Harman NL, Khansari A, Jafarzadeh H, Malkhassian G, Sabeti M, Aminoshariae A, Kishen A, Sale JEM, Shah PS, Azarpazhooh A. Development of a Core Outcome Set in Endodontics (COS-ENDO): Part 4 - COS-ENDO for Studies of Vital Pulp Therapy in Permanent Teeth. J Endod 2025; 51:442-456. [PMID: 39892665 DOI: 10.1016/j.joen.2025.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2024] [Accepted: 01/14/2025] [Indexed: 02/04/2025]
Abstract
INTRODUCTION Methodological heterogeneity and reporting bias complicate interpreting endodontic outcomes. Supported by the American Association of Endodontists and its Foundation, this study developed the Core Outcome Set for Endodontics (COS-ENDO) to standardize reporting for studies of Nonsurgical Root Canal Treatment/Retreatment, Surgical Endodontics, Vital Pulp Therapy, Apexification, and Regenerative Endodontics. This article, Part 4 of a 5-part series, focuses on COS-ENDO for Vital Pulp Therapy, while other parts address the remaining treatments. METHODS Outcomes were identified through a scoping review and a web-based survey of American Association of Endodontists practicing members. In a 2-round Delphi survey, clinicians, patients, and researchers rated outcomes on a 9-point scale. Ratings were assessed against consensus criteria, and a virtual meeting finalized COS-ENDO. RESULTS Of the 97 invited participants to Round 1, 77 registered, and 73 (24 Academicians/Researchers, 26 Clinicians, and 23 Patients or their parents/caregivers) assessed 46 outcomes, with 17 excluded. The remaining outcomes-4 achieving consensus for inclusion and 25 lacking consensus-advanced to Round 2 for re-rating by 70 participants. This resulted in 10 outcomes achieving consensus for inclusion, and 19 lacking consensus. In the final meeting, 16 participants finalized the COS-ENDO for Vital Pulp Therapy studies, including Tooth survival, Pain, Signs of infection, Radiographic evidence of maintained periradicular health, Continued root development, Success, Functional tooth, Need for further intervention, and Adverse events/Complications. CONCLUSION COS-ENDO is an important step in standardizing outcome reporting in endodontics, ensuring consistent reporting and enhancing research utility. Further efforts are needed to establish optimal measurement methods.
Collapse
Affiliation(s)
- Maryam Zanjir
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada
| | - Elaine Cardoso
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - Nicola L Harman
- Department of Health Data Science, University of Liverpool, Liverpool, United Kingdom
| | - Ava Khansari
- Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
| | - Hamid Jafarzadeh
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Endodontics, School of Dentistry, West Virginia University, Morgantown, West Virginia
| | - Gevik Malkhassian
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada
| | - Mike Sabeti
- School of Dentistry, University of California San Francisco, San Francisco, California
| | - Anita Aminoshariae
- Department of Endodontics, School of Dental Medicine, Case Western Reserve University, Cleveland, Ohio
| | - Anil Kishen
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada; The Kishen Lab, Dental Research Institute, University of Toronto, Toronto, Ontario, Canada
| | - Joanna E M Sale
- St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - Prakesh S Shah
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - Amir Azarpazhooh
- Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada; Department of Dentistry, Mount Sinai Hospital, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
| |
Collapse
|
33
|
Dewidar O, Sayfi S, Pardo JP, Welch V, Wright GC, Akl EA, Khabsa J, Lin JS, Wang X, Darzi AJ, Lotfi T, Pottie K, Khawandi J, Morgan RL, Pereira Nunes Pinto AC, Tufte J, Brennan SE, Motilall A, Oloyede O, Mustafa RA, Petkovic J, Nieuwlaat R, Xia J, Yao X, Chi Y, Schünemann HJ, Tugwell P. Enhancing health equity considerations in guidelines: health equity extension of the GIN-McMaster Guideline Development Checklist. EClinicalMedicine 2025; 82:103135. [PMID: 40224676 PMCID: PMC11992520 DOI: 10.1016/j.eclinm.2025.103135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/14/2024] [Revised: 02/11/2025] [Accepted: 02/12/2025] [Indexed: 04/15/2025] Open
Abstract
Background Practice guidelines may reduce health inequities by addressing preventable and unjust differences in health. However, health equity considerations are often inadequately integrated into the guideline planning and development process. This article describes a pragmatic approach to enhancing health equity considerations within guidelines by introducing an extension to the GIN-McMaster Guideline Development Checklist (GDC). Methods We reviewed the latest guidance on enhancing health equity considerations in guideline development to draft the checklist and deployed a global online survey from March 27th, 2024, to May 13th, 2024 to gather consensus. We conducted a methodological review of guideline development handbooks to identify best practices in health equity considerations. An advisory board comprised of diverse interest-holders informed the development of the checklist. We made revisions based on the survey feedback and review findings. Findings We present 21 extension items spanning 16 of the 18 guideline development topics from the GIN-McMaster GDC. Key additions include planning for engagement with individuals experiencing inequities in guideline development activities, applying an equity lens, and considering health equity in recommendation formulation, dissemination and implementation strategies. This checklist gives value to lived experiences to enrich health equity assessments, complementing empirical evidence to inform guideline recommendations. Guideline developers should assess guideline sensitivity to health equity to determine resource prioritization for optimal implementation of the extension items. Interpretation The GIN-McMaster health equity extension provides guidance for the streamlined integration of health equity considerations throughout the guideline development process. Using this tool alongside the original GIN-McMaster GDC may lead to more equitable and impactful guidelines. Funding This project was partially funded by Public Health Agency of Canada. The funder was not involved in the conceptualization or design or the conduct of the project.
Collapse
Affiliation(s)
- Omar Dewidar
- Temerty School of Medicine, University of Toronto, Toronto, Ontario, Canada
- Bruyère Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada
| | - Shahab Sayfi
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Jordi Pardo Pardo
- Ottawa Centre for Health Equity, University of Ottawa, Ottawa, Ontario, Canada
| | - Vivian Welch
- Bruyère Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada
- School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
| | - Grace C. Wright
- Association of Women in Rheumatology, USA
- Grace C Wright MD PC Inc, New York, NY, USA
| | - Elie A. Akl
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
- Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
| | - Joanne Khabsa
- Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon
| | - Jennifer S. Lin
- Kaiser Permanente Evidence-based Practice Center, Kaiser Permanente Center for Health Research, Portland, OR, USA
| | - Xiaoqin Wang
- Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada
- University of Ottawa Heart Institute, Ottawa, Ontario, Canada
| | - Andrea J. Darzi
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
- Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada
- Michael G. DeGroote National Pain Centre, McMaster University, Hamilton, Ontario, Canada
| | - Tamara Lotfi
- Cochrane Canada & GRADE McMaster, Health Research Methods, Evidence & Impact (HEI), McMaster University, Hamilton, Ontario, Canada
| | - Kevin Pottie
- CT Lamont Centre for Primary Care, Bruyère Health Research Institute, Ottawa, Ontario, Canada
- Department of Family Medicine, Western University, London, Ontario, Canada
| | - Jana Khawandi
- Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA
| | - Rebecca L. Morgan
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
- School of Medicine, Case Western Reserve University, Cleveland, OH, USA
| | | | - Janice Tufte
- Cochrane Consumer, COVID-END Equity group, Seattle, WA, USA
| | - Sue E. Brennan
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - Ashley Motilall
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
- Michael G. DeGroote Cochrane Canada, MacGRADE Centres, McMaster University, Hamilton, Ontario, Canada
| | | | - Reem A. Mustafa
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
- Department of Internal Medicine, University of Kansas Health System, Kansas City, KS, USA
| | - Jennifer Petkovic
- Bruyère Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada
| | - Robby Nieuwlaat
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
- Michael G. DeGroote Cochrane Canada, MacGRADE Centres, McMaster University, Hamilton, Ontario, Canada
| | - Jun Xia
- Nottingham Ningbo GRADE Centre, University of Nottingham Ningbo, China
- School of Economics, University of Nottingham Ningbo, China
| | - Xiaomei Yao
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
- Department of Oncology, McMaster University, Hamilton, Ontario, Canada
| | - Yuan Chi
- Yealth Network, Beijing Yealth Technology Co., Ltd, China
| | - Holger J. Schünemann
- Clinical Epidemiology and Research Center (CERC), Humanitas University & Humanitas Research Hospital, Milan, Italy
- WHO Collaborating Center for Evidence-Based Decision-Making in Health, Humanitas University, Milan, Italy
| | - Peter Tugwell
- Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
- Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
- WHO Collaborating Centre for Knowledge Translation and Health Technology Assessment in Health Equity, Bruyère Health Research Institute, Ottawa, Ontario, Canada
| |
Collapse
|
34
|
Doering BK, Hanauer C, Telaar B, Rosner R. [What grief counsellors should know about psychological disorders - Results of a Delphi survey among experts]. ZEITSCHRIFT FUR EVIDENZ, FORTBILDUNG UND QUALITAT IM GESUNDHEITSWESEN 2025; 193:93-101. [PMID: 40016029 DOI: 10.1016/j.zefq.2024.12.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/08/2024] [Revised: 12/23/2024] [Accepted: 12/28/2024] [Indexed: 03/01/2025]
Abstract
BACKGROUND Stepped-care approaches can improve the support for the bereaved. This requires the selection of interventions according to individual support needs. Grief counsellors are in a position to identify bereaved persons possibly suffering from a psychological disorder and to refer them to psychotherapeutic or medical treatment. However, it remains unclear what knowledge regarding psychological disorders and which skills grief counsellors need for this task. METHOD We conducted an online Delphi consensus study with 17 experts of grief counselling in three consecutive survey rounds. The first round qualitatively identified the required knowledge regarding psychological disorders and the respective skills. In the subsequent rounds, the experts rated the topics concerning their relevance, whether they should be part of a training curriculum and whether they are adequately considered in current curricula. Descriptive analyses were applied. Consensus was reached if at least 50 % of the experts rated a topic as rather relevant, and 80 % endorsed the topic for a training curriculum. Expert comments were used to generate recommendations that were evaluated for consensus. RESULTS The qualitative analysis identified 39 topics, and 26 reached a consensus. Of these, six referred to "knowledge about grief", five to "knowledge about psychological disorders", and 15 to professional, interpersonal, and relationship and communication skills. Experts' opinions on whether sufficient consideration is given to these topics in current curricula varied greatly between the topics. DISCUSSION The experts reached a consensus regarding the areas of knowledge about psychological disorders and the specific skills to be taught. At the same time, there appears to be a high degree of heterogeneity between the various training and continuing education programmes with regard to imparting knowledge to identify the need for therapeutic support. CONCLUSION The present recommendations can be used to inform and optimise the content of training curricula for grief counsellors with regard to the identification of bereaved persons with increased therapeutic support needs.
Collapse
Affiliation(s)
- Bettina K Doering
- Klinische Psychologie und Psychotherapie II, Institut für Psychologie, Christian-Albrechts-Universität zu Kiel, Kiel, Deutschland.
| | - Christina Hanauer
- Biologische und Klinische Psychologie, Philosophische Fakultät, Katholische Universität Eichstätt-Ingolstadt, Eichstätt, Deutschland
| | - Berit Telaar
- Biologische und Klinische Psychologie, Philosophische Fakultät, Katholische Universität Eichstätt-Ingolstadt, Eichstätt, Deutschland
| | - Rita Rosner
- Biologische und Klinische Psychologie, Philosophische Fakultät, Katholische Universität Eichstätt-Ingolstadt, Eichstätt, Deutschland
| |
Collapse
|
35
|
Chrysohoou C, Marketou M, Aktsiali M, Griveas I. A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum. ESC Heart Fail 2025; 12:1132-1140. [PMID: 39479772 PMCID: PMC11911575 DOI: 10.1002/ehf2.15153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2024] [Revised: 09/28/2024] [Accepted: 10/14/2024] [Indexed: 03/18/2025] Open
Abstract
The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece. Median score used to determine the level of agreement and disagreement index (DI) used to determine the level of consensus for each statement. Statements divided in four sectors: hyperkalaemia risk management, preventative measures, treatment and collaboration between specialties. The rate of the first round of the consensus was 94.6%. Median score was >7 for 36 of 37 statements and DI ≤ 1 for 35 of 37. Among other statements, consensus reached for recognizing levels K+ > 5.0 mEq/L as associated with elevated mortality risk; retaining renin-angiotensin-aldosterone system inhibitors (RAASi) on maximum recommended dose for cardiorenal patients; and using novel K+ binders to help enabling guideline-recommended doses of RAASi therapy. Cardiologists compared to nephrologists showed higher reluctance to discontinue down-titrate RAASi and MRA in patients with K+ levels above 5 mEq/L. Additionally, 88.9% of nephrologists and 71.4% of cardiologists agreed that cross-specialty alignment on a serum K+ concentration level (K > 5.5 mEq/L) is needed to initiate hyperkalaemia treatment. Both cardiologists and nephrologists showed disagreement with the statement on keeping titration in cardiorenal patients with K+ > 5.5 mEq/L or preserving fruit and vegetable consumption when moderate or severe hyperkalaemia exhibits. This Delphi project pointed out nephrologists' and cardiologists' agreement on hyperkalaemia management in cardiorenal patients; thus, it can help a cross-specialty optimal management of cardiorenal patients, with hyperkalaemia not being an obstacle for disease-optimizing therapy. Novel potassium binding agents can enable guideline-recommended doses of potassium-sparing medication.
Collapse
Affiliation(s)
| | - Maria Marketou
- Cardiology DepartmentPAGNI University HospitalHeraklionGreece
| | | | - Ioannis Griveas
- Nephrology DepartmentArmy Share Fund Hospital of AthensAthensGreece
| |
Collapse
|
36
|
Verhoeven R, Kooi EMW, Obermann-Borst SA, Labrie NHM, Geurtzen R, Verhagen AAE, Hulscher JBF. Key factors in parental end-of-life decision making for surgical necrotizing enterocolitis: A Delphi study. Early Hum Dev 2025; 203:106219. [PMID: 40023127 DOI: 10.1016/j.earlhumdev.2025.106219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2024] [Revised: 02/07/2025] [Accepted: 02/09/2025] [Indexed: 03/04/2025]
Abstract
BACKGROUND/OBJECTIVES In severe cases of necrotizing enterocolitis (NEC) in preterm neonates, surgery may be the only option for survival. However, the consequences of active treatment are not always in the infant's best interest, urging parents and physicians to consider palliative care as an alternative. This study aims to identify key factors parents prioritize when making this decision, as a preliminary step towards developing a decision support tool. METHODS Three Dutch parent panels (without experience with NEC/preterm birth, with experience but without loss, and with loss due to NEC/preterm birth) were asked to rate 31 literature-based and self-suggested decision factors. Factors were rated on a scale of 1 to 9 in a two-round Delphi study. Factors that reached a median score of six or higher by one or more panels after the second Delphi round were discussed in a consensus meeting of the steering committee. RESULTS Sixty-six participants completed both Delphi rounds. Nine factors were excluded after the final round, including parental physical and mental health, finances, and religion. Of the other 22 factors, the steering committee decided upon 15 key factors to serve as a base for the decision support tool. Most important factors included chance of death, short- and long-term physical consequences, and future independence. Additionally, parents were influenced by doctors' opinions and feelings of responsibility and hope. CONCLUSION This study highlights fifteen decision factors for Dutch parents facing surgical NEC. These insights will inform the development of a decision support tool aiding parents in making informed end-of-life decisions.
Collapse
Affiliation(s)
- Rosa Verhoeven
- Department of Surgery, Division of Pediatric Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Neonatology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
| | - Elisabeth M W Kooi
- Department of Neonatology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | | | - Nanon H M Labrie
- Department of Language, Literature & Communication, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Department of Pediatrics and Neonatology, OLVG, Amsterdam, the Netherlands
| | - Rosa Geurtzen
- Amalia Children's Hospital, Department of Neonatology, Radboud University Medical Center, Nijmegen, the Netherlands
| | - A A Eduard Verhagen
- Department of Pediatrics, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Jan B F Hulscher
- Department of Surgery, Division of Pediatric Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| |
Collapse
|
37
|
Rojas M, Guilera G, Arias-Patiño E, Barrios M, Gómez-Benito J. Methodological considerations in cross-sectional studies validating the International Classification of Functioning, Disability and Health (ICF) Core-Sets: a systematic review. Disabil Rehabil 2025; 47:1912-1931. [PMID: 39162291 DOI: 10.1080/09638288.2024.2390047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2024] [Revised: 08/03/2024] [Accepted: 08/03/2024] [Indexed: 08/21/2024]
Abstract
PURPOSE To describe and analyze the methodological characteristics and quality of cross-sectional studies that have validated an ICF-CS. MATERIALS AND METHODS A systematic review was conducted to identify empirical studies published in English that validated any ICF-CS using a cross-sectional design. Databases searched included Web of Science, Scopus, CINAHL, PubMed, Embase, and PsycINFO. The search was conducted in November 2022 with an update in October 2023. Two independent reviewers coded studies that met the inclusion criteria and assessed their methodological quality and risk of bias using the AXIS tool. Synthesis was performed by calculating frequencies and percentages. RESULTS 87 articles validating 24 ICF-CSs were analyzed. Most articles showed strengths in consistency between study objectives and the outcome variables measured. However, a large majority did not report sample size calculation (up to 94.2% in Delphi studies), and few validation studies were conducted in the WHO regions of Africa and the Eastern Mediterranean. CONCLUSIONS The quality of cross-sectional studies validating ICF-CSs was satisfactory, although several articles did not describe aspects such as sample size calculation. Validity evidence for ICF-CS studies could be improved by conducting more multicenter studies, replicating ICF-CS validation studies in different WHO regions, and through synthesis of existing research.
Collapse
Affiliation(s)
- M Rojas
- Department of Social Psychology and Quantitative Psychology, Faculty of Psychology, University of Barcelona, Barcelona, Spain
- Group on Measurement Invariance and Analysis of Change (GEIMAC), Institute of Neurosciences, University of Barcelona, Barcelona, Spain
| | - G Guilera
- Department of Social Psychology and Quantitative Psychology, Faculty of Psychology, University of Barcelona, Barcelona, Spain
- Group on Measurement Invariance and Analysis of Change (GEIMAC), Institute of Neurosciences, University of Barcelona, Barcelona, Spain
| | - E Arias-Patiño
- Department of Social Psychology and Quantitative Psychology, Faculty of Psychology, University of Barcelona, Barcelona, Spain
- Group on Methods and Instruments for Research in Behavioral Sciences, Universidad Nacional de Colombia, Bogotá, Colombia
| | - M Barrios
- Department of Social Psychology and Quantitative Psychology, Faculty of Psychology, University of Barcelona, Barcelona, Spain
- Group on Measurement Invariance and Analysis of Change (GEIMAC), Institute of Neurosciences, University of Barcelona, Barcelona, Spain
| | - J Gómez-Benito
- Department of Social Psychology and Quantitative Psychology, Faculty of Psychology, University of Barcelona, Barcelona, Spain
- Group on Measurement Invariance and Analysis of Change (GEIMAC), Institute of Neurosciences, University of Barcelona, Barcelona, Spain
| |
Collapse
|
38
|
De Poli C, Oyebode J, Airoldi M, Stevens M, Capstick A, Mays N, Clark M, Driessen A, Rivas C, Penhale B, Fletcher JR, Russell AM. Fitting a square peg in a round hole? A mixed-methods study on research ethics and collaborative health and social care research involving 'vulnerable' groups. Health Res Policy Syst 2025; 23:40. [PMID: 40170089 PMCID: PMC11963353 DOI: 10.1186/s12961-025-01290-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Accepted: 01/29/2025] [Indexed: 04/03/2025] Open
Abstract
BACKGROUND Current research ethics frameworks that oversee health and social care research, in the United Kingdom and internationally, originated in biomedical research, having positivist underpinnings and an orientation towards experimental research. Limitations of these frameworks have been extensively documented including with regard to health and social care research that adopts collaborative approaches. This article contributes to debates about how the research ethics system deals with collaborative research with groups labelled or potentially perceived as vulnerable, and identifies practical recommendations to ensure a better fit between principles and practices of research ethics and those of collaborative research. METHODS We conducted a two-round online Delphi study with 35 academic researchers with experience of collaborative research involving vulnerable groups and of seeking research ethics approval in England (United Kingdom), followed by a focus group with eight members of the Delphi panel. The Delphi questionnaire, organised in 12 themes, comprised 66 statements about how researchers experience research ethics review and how the research ethics system could be improved. The focus group discussed the results of the Delphi study to generate practical recommendations. RESULTS By the end of the second Delphi round, only one statement relating to the experience of the current research ethics system reached consensus, signalling heterogeneous experiences among researchers working in this field. A total of 32 statements on potential improvements reached consensus. The focus group discussed the 14 Delphi statements with the highest levels of consensus and generated 12 practical recommendations that we grouped into three clusters (1. Endorsing the 'collaborative' dimension of collaborative research; 2. Allowing flexibility; and 3. Strengthening the relational and ongoing nature of ethical research practice). CONCLUSIONS This work provides further empirical evidence of how the research ethics system deals with collaborative research involving 'vulnerable' groups. It also offers practical recommendations to ensure that the collaborative dimension of such research receives proper ethical scrutiny, to introduce a degree of flexibility in research ethics processes and supporting documents, and to replace formal, one-off research ethics approvals with ongoing, situated, relational ethical processes and practices.
Collapse
Affiliation(s)
- Chiara De Poli
- Care Policy and Evaluation Centre, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, United Kingdom.
| | - Jan Oyebode
- Centre for Applied Dementia Studies, Faculty of Health Studies, University of Bradford, Richmond Road, Bradford, BD7 1DP, United Kingdom
| | - Mara Airoldi
- Blavatnik School of Government, Radcliffe Observatory Quarter, University of Oxford, 120 Walton St, Oxford, OX2 6GG, United Kingdom
| | - Martin Stevens
- The NIHR Policy Research Unit in Health & Social Care Workforce, King's College London, Virginia Woolf Building, Kingsway, London, WC2B 6LE, United Kingdom
| | - Andrea Capstick
- Centre for Applied Dementia Studies, Faculty of Health Studies, University of Bradford, Richmond Road, Bradford, BD7 1DP, United Kingdom
| | - Nicholas Mays
- Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, United Kingdom
| | - Michael Clark
- Care Policy and Evaluation Centre, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, United Kingdom
| | - Annelieke Driessen
- Anthropology Department, University of Amsterdam, Nieuwe Achtergracht 166, 1018 WV, Amsterdam, The Netherlands
| | - Carol Rivas
- Social Research Institute, University College London, 27 Woburn Square, London, WC1H 0AA, United Kingdom
| | - Bridget Penhale
- School of Health Sciences, University of East Anglia, Norwich, NR4 7TJ, United Kingdom
| | - James R Fletcher
- School of Management, University of Bath, Convocation Avenue, Claverton Down, Bath, BA2 7AY, United Kingdom
| | - Amy M Russell
- Faculty of Medicine & Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, LS2 9NL, United Kingdom
| |
Collapse
|
39
|
Morris J, Jones M, DeRuyter F, Rabinowitz A, Reinkensmeyer DJ. Rehabilitation Engineering Research Center on Mobile Rehabilitation: State of the Science Conference Report-Future Directions for mRehab for People with Disabilities. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2025; 22:532. [PMID: 40283757 PMCID: PMC12026943 DOI: 10.3390/ijerph22040532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/02/2024] [Revised: 02/04/2025] [Accepted: 02/19/2025] [Indexed: 04/29/2025]
Abstract
This article summarizes proceedings of the State of the Science (SOS) Conference on Information and Communication Technology (ICT) Access for Mobile Rehabilitation, convened by the Rehabilitation Engineering Research Center on Mobile Rehabilitation (mRehab RERC), which is funded by the U.S. National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR). The conference sought to assess the current state of the field and identify future research and development priorities for the field of mobile rehabilitation. The conference comprised four sessions addressing the following broad areas: (1) adherence to and effectiveness of home therapeutic exercise programs (HEPs); (2) technology for remote monitoring to support rehabilitation in the home and community (mRehab); (3) analytic techniques for using "big data" generated by remote monitoring to customize home exercise; and (4) barriers and facilitators to adoption of mRehab technology. Priorities for further research and development were identified using a three-stage process of gathering and refining expert opinions informed by the Delphi method for identifying future states in specific fields of inquiry. Results: Eight research and six technology development priorities were identified in the third and last stage of refinement of the initial set of priorities identified during the SOS Conference.
Collapse
Affiliation(s)
- John Morris
- Virginia C. Crawford Research Institute, Shepherd Center, Atlanta, GA 30309, USA; (M.J.); (F.D.)
| | - Mike Jones
- Virginia C. Crawford Research Institute, Shepherd Center, Atlanta, GA 30309, USA; (M.J.); (F.D.)
| | - Frank DeRuyter
- Virginia C. Crawford Research Institute, Shepherd Center, Atlanta, GA 30309, USA; (M.J.); (F.D.)
| | - Amanda Rabinowitz
- Jefferson Moss Rehabilitation Research Institute, Elkins Park, PA 19027, USA;
| | | |
Collapse
|
40
|
Yue Z, Zhou D, Zeng M, Li J, Zheng R. Drug prescription for the management of gastrointestinal and skin symptoms in cancer patients by advanced practice nurses in China: a Delphi method. BMJ Open 2025; 15:e089803. [PMID: 40164483 PMCID: PMC11962776 DOI: 10.1136/bmjopen-2024-089803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/09/2024] [Accepted: 03/10/2025] [Indexed: 04/02/2025] Open
Abstract
BACKGROUND The authority to prescribe drugs has been reserved only for the medical community, mainly clinicians. Recently, more and more countries worldwide have begun implementing reforms to grant advanced practice nurses (APNs) the authority to prescribe from the legislative level. This study aimed to explore the prescription drugs and forms for gastrointestinal and dermatological symptom management of cancer patients that APNs can prescribe in China. DESIGN A qualitative study reported in accordance with Conducting and REporting of DElphi Studies guidelines. The modified Delphi technique with two-round email consultations among 36 experts was applied. METHODS We conducted a study from January 2022 to March 2022 to reach a consensus among medical, nursing and pharmacy experts about drugs that nurses may prescribe for gastrointestinal and dermatological symptom management in cancer patients. RESULTS The expert authority coefficients are 0.95 and 0.96, respectively. A total of 35 drugs in 16 categories could be prescribed by APNs for gastrointestinal and dermatological symptoms management in China. Among them, three drugs were determined to be prescribed collaboratively, and 32 drugs were determined to be prescribed independently. CONCLUSIONS The drug prescription formulated in this study is the basis for APNs to prescribe drugs for controlling gastrointestinal and skin symptoms for cancer patients in mainland China. The results are important as a guide for formulating and implementing policies related to nurse prescribing and will provide some reference for future nurse prescribing in China.
Collapse
Affiliation(s)
- Zhiying Yue
- Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, China
| | - Dan Zhou
- Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, China
| | - Mingli Zeng
- Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, China
| | - Junying Li
- Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, China
| | - Rujun Zheng
- Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, China
| |
Collapse
|
41
|
Allegranzi B, Tartari E, Kilpatrick C, Storr J, Bellare N, Bana J, Flávia Santos A, Charnaud S, Ross AL, Schwaber MJ, Pittet D. WHO global research agenda for hand hygiene improvement in health care: a Delphi consensus study. Infect Control Hosp Epidemiol 2025; 46:1-16. [PMID: 40109269 PMCID: PMC7617569 DOI: 10.1017/ice.2025.32] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/22/2025]
Abstract
OBJECTIVE To identify global research priorities for improving hand hygiene in healthcare settings and develop a 2023-2030 research agenda to guide funding, coordinate research, promote investment, and inform policy for enhanced healthcare quality and safety. DESIGN Expert consensus study using a modified Delphi process. PARTICIPANTS A 105-member panel of international hand hygiene experts including the World Health Organization (WHO) Technical Advisory Group of Experts on Hand Hygiene in Healthcare representing all WHO regions and World Bank income levels. METHODS The research priorities were identified through a multiphase approach including a meta-review to establish knowledge gaps and inform initial priorities, followed by expert consultations using a modified Delphi process. 192 preliminary priorities were included in a two-round Delphi survey. Experts rated each priority in the first round, and then reviewed and adjusted responses based on the panel's aggregated, anonymous responses in the second round. Ratings were collected on a five-point Likert scale. Consensus was defined as a combined "strongly agree" and "agree" frequency of at least 70%. RESULTS Consensus was achieved for 178 of 192 priorities (92.7%), categorized into six domains: system change; training and education; evaluation and feedback; reminders and communications; institutional safety climate; and hand hygiene improvement impact on healthcare-associated infections and antimicrobial resistance. Of these, 121 priorities reached >80% consensus. The Delphi process, maintained a 92% response rate over two rounds. CONCLUSIONS A structured consensus process yielded a research agenda to address gaps in hand hygiene improvement, supporting enhanced healthcare quality and safety globally.
Collapse
Affiliation(s)
- Benedetta Allegranzi
- Infection Prevention and Control Unit and Hub, Department of Integrated Health Services, World Health Organization, Geneva, Switzerland
| | - Ermira Tartari
- Infection Prevention and Control Unit and Hub, Department of Integrated Health Services, World Health Organization, Geneva, Switzerland
- Faculty of Health Sciences, University of Malta, Msida, Malta
| | - Claire Kilpatrick
- Infection Prevention and Control Unit and Hub, Department of Integrated Health Services, World Health Organization, Geneva, Switzerland
| | - Julie Storr
- Infection Prevention and Control Unit and Hub, Department of Integrated Health Services, World Health Organization, Geneva, Switzerland
| | - Nita Bellare
- Infection Prevention and Control Unit and Hub, Department of Integrated Health Services, World Health Organization, Geneva, Switzerland
| | | | - Ana Flávia Santos
- CEGIST, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal
| | - Sarah Charnaud
- Research for Health department, World Health Organization, Geneva, Switzerland
| | - Anna Laura Ross
- Research for Health department, World Health Organization, Geneva, Switzerland
| | - Mitchell J. Schwaber
- National Center for Infection Control, Israel Ministry of Health, Jerusalem, Israel
| | - Didier Pittet
- Faculty of Medicine, University of Geneva, Geneva, Switzerland
| |
Collapse
|
42
|
Atukunda EC, Mugyenyi GR, Haberer JE, Siedner MJ, Musiimenta A, Najjuma JN, Obua C, Matthews LT. Integration of a Patient-Centered mHealth Intervention (Support-Moms) Into Routine Antenatal Care to Improve Maternal Health Among Pregnant Women in Southwestern Uganda: Protocol for a Randomized Controlled Trial. JMIR Res Protoc 2025; 14:e67049. [PMID: 40105879 PMCID: PMC11966083 DOI: 10.2196/67049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2024] [Revised: 02/15/2025] [Accepted: 02/18/2025] [Indexed: 03/20/2025] Open
Abstract
BACKGROUND Mobile health (mHealth) interventions that leverage social support (SS) can improve partner involvement and pregnancy experiences and promote antenatal care (ANC) attendance and skilled births. In our previous studies, we used behavioral frameworks to develop a user-centered mHealth-based, audio SMS text messaging app to support pregnant individuals to use maternity care services in rural Uganda (Support-Moms app). In our pilot study, we observed high intervention uptake, acceptability, and feasibility, as well as increased ANC attendance and skilled births. OBJECTIVE With the promising pilot data, we propose a type 1 hybrid implementation-effectiveness trial to test if this novel patient-centered automated and customized mHealth-based SS intervention is effective and cost-effective enough to warrant future large-scale implementation into Uganda's routine maternity care. METHODS We will physically recruit 824 pregnant women at <20 weeks of gestation living in Mbarara and Mitooma districts, southwestern Uganda, and randomize them (1:1) to receive standard of care or the Support-Moms app, with at least 2 of their identified social supporters. Our primary outcome will be the proportion of skilled births. Secondary outcomes will include number of ANC visits, institution-based delivery, mode of infant delivery, preterm birth, birth weight, SS, obstetric complications, and deaths (maternal, fetal, and newborn). We will assess other implementation, service, and client outcomes through study records, the mHealth platform, and questionnaires with all women in the intervention, their social supporters, health care providers (HCPs), and managers from participating facilities. We will conduct face-to-face in-depth exit interviews with 30 purposively selected intervention participants and 15 facility HCPs and managers to explore implementation strategies for scale-up. Annual maternity resource allocations, costs, number of ANC visits, and deliveries will be assessed from facility records up to 36 months after implementation. We will estimate incremental cost-effectiveness ratios concerning cost per additional HCP-led delivery, per death averted, and per quality-adjusted life year gained as cost-effectiveness measures. RESULTS This study was funded in September 2023. Ethics approval was obtained in February 2024, and actual data collection started in March 2024. As of January 2025, 75% (618/824) of all projected study participants provided consent and were recruited into the study. Participants are expected to be followed up until delivery, and 15% (124/824) have so far exited. Data analysis for the trial is expected to start as soon as the last participant exits from the study. The qualitative interviews will start in April 2025, and data will be analyzed and published as soon as data collection is done, which is expected in March 2027. CONCLUSIONS We are testing the feasibility, acceptability, and cost-effectiveness of implementing Support-Moms into routine maternity care from individual and facility perspectives. We hypothesize that Support-Moms will be an effective and cost-effective strategy to improve maternity service use for women in rural Uganda and similar settings. TRIAL REGISTRATION ClinicalTrials.gov NCT05940831; https://clinicaltrials.gov/study/NCT05940831. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) DERR1-10.2196/67049.
Collapse
Affiliation(s)
| | | | - Jessica E Haberer
- Department of Medicine and Center for Global Health, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States
| | - Mark J Siedner
- Department of Medicine and Center for Global Health, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States
| | | | | | - Celestino Obua
- Mbarara University of Science and Technology, Mbarara, Uganda
| | - Lynn T Matthews
- Division of Infectious Diseases, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States
| |
Collapse
|
43
|
Dygrýn J, Brazo-Sayavera J, Cruz J, Gebremariam MK, Ribeiro JC, Capranica L, MacDonncha C, Netz Y. Definitions of determinants of physical activity behaviour: process and outcome of consensus from the DE-PASS expert group. Int J Behav Nutr Phys Act 2025; 22:34. [PMID: 40102955 PMCID: PMC11921651 DOI: 10.1186/s12966-025-01728-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2024] [Accepted: 02/28/2025] [Indexed: 03/20/2025] Open
Abstract
BACKGROUND Despite extensive research on physical activity behaviour (PAB), consensus is lacking on related terms and definitions, thereby hindering the ability to compare findings between studies and to develop reliable assessment tools. This study therefore aimed to establish consensus on the definitions of key PAB determinants. METHODS First, an international expert steering committee was established, comprising members of the European Cooperation in Science and Technology (COST) action "DEterminants of Physical ActivitieS in Settings" (DE-PASS). Recently published review-level studies were used to identify key determinants of PAB. Two independent reviewers systematically reviewed the literature to catalogue the range of definitions used for key determinants of PAB (steps 1-2). A two-round modified Delphi survey was conducted online from February to September 2023, to determine the optimal definition for each determinant. In round 1, experts selected the most suitable definition for each of the 41 initially identified determinants. In round 2, experts ranked the appropriateness of the definition selected from round 1 on a 5-point Likert scale. Consensus was defined a priori as ≥ 75% agreement on the definition (i.e., ratings of ≥ 4 points). A professional English language expert ensured concise, coherent wording and high-quality editing of the definitions (steps 3-6). RESULTS Eighty-five experts in PAB research participated in round 1, and sixty-nine experts in round 2. Consensus of definitions was achieved for 39 of the 41 determinants (88.4%-98.6% agreement). The consensus threshold was not achieved for two determinants: genetic profile and regulation (69.6%) and backyard access/size (73.9%). CONCLUSIONS The findings of this study offer a consensus-based set of definitions for 39 key determinants of PAB. These definitions can be used homogenously in academic research on physical activity.
Collapse
Affiliation(s)
- Jan Dygrýn
- Faculty of Physical Culture, Palacký University Olomouc, třída Míru 117, Olomouc, 779 00, Olomouc, Czech Republic.
| | - Javier Brazo-Sayavera
- Department of Sports and Computer Science, Universidad Pablo de Olavide, Seville, Spain
| | - Joana Cruz
- Center for Innovative Care and Health Technology (ciTechCare), School of Health Sciences of the Polytechnic University of Leiria, Leiria, Portugal
| | - Mekdes Kebede Gebremariam
- Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway
- Sustainable Health Unit, University of Oslo, Oslo, Norway
| | - José Carlos Ribeiro
- Research Centre in Physical Activity, Health and Leisure, Faculty of Sport, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal
| | - Laura Capranica
- Department of Movement, Human and Health Sciences, University of Rome Foro Italico, Rome, Italy
| | - Ciaran MacDonncha
- Department of Physical Education and Sport Sciences and Health Research Institute, University of Limerick, Limerick, Ireland
| | - Yael Netz
- Levinsky-Wingate Academic College, Wingate Campus, Netanya, Israel
- Department of Health Promotion and Rehabilitation, Lithuanian Sports University, Kaunas, Lithuania
| |
Collapse
|
44
|
Dunbar M, Agarwal S, Venkatesan C, Vollmer B, Scelsa B, Pardo AC, Tarui T, Hart AR, Mulkey SB, Lemmon ME, Gano D. Fetal intracerebral hemorrhage: review of the literature and practice considerations. Pediatr Res 2025:10.1038/s41390-025-04000-5. [PMID: 40097829 DOI: 10.1038/s41390-025-04000-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2024] [Revised: 02/20/2025] [Accepted: 02/25/2025] [Indexed: 03/19/2025]
Abstract
Fetal intracerebral hemorrhage is increasingly recognized on prenatal imaging. In this review, we discuss clinically relevant aspects of fetal intracerebral hemorrhage, including germinal matrix-intraventricular hemorrhage, as well as intraparenchymal hemorrhage. We discuss current clinical practice for prenatal counseling and postnatal management of fetal intracerebral hemorrhage, and offer practical recommendations for clinicians. We propose standardized terminology for classification of fetal intracerebral hemorrhage to be used in future research. We also highlight gaps in the literature and priorities for future research, namely the need for prospective large-scale studies to better understand underlying etiologies and neurodevelopmental outcomes in fetal intracerebral hemorrhage. IMPACT STATEMENT: We discuss the diverse etiologies and outcomes of fetal intracerebral hemorrhage, and propose standardized terminology for classification. We outline current practice and offer practical recommendations for management and counseling of fetal intracerebral hemorrhage, recognizing the need for capacity-building in the newly emerging subspecialty of fetal neurology. We highlight gaps in the literature and research priorities in fetal intracerebral hemorrhage to promote collaborative research, and the development of interventions to improve pregnancy and child outcomes.
Collapse
Affiliation(s)
- Mary Dunbar
- Department of Pediatrics, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada
| | - Sonika Agarwal
- Division of Neurology & Pediatrics, Children's Hospital of Philadelphia; Division of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
| | - Charu Venkatesan
- Division of Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA
| | - Brigitte Vollmer
- Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton; Paediatric and Neonatal Neurology, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - Barbara Scelsa
- Department of Pediatric Neurology, Buzzi Children's Hospital, University of Milan, Milan, Italy
| | - Andrea C Pardo
- Department of Pediatrics, Division of Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Tomo Tarui
- Division of Pediatric Neurology, Hasbro Children's Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA
| | - Anthony R Hart
- Department of Paediatric Neurology, King's College Hospital NHS Foundation Trust, London, UK
| | - Sarah B Mulkey
- Departments of Neurology and Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA
- Zickler Family Prenatal Pediatrics Institute, Children's National Hospital, Washington, DC, USA
| | - Monica E Lemmon
- Department of Pediatrics and Population Health Sciences, Duke University School of Medicine, Durham, NC, England
| | - Dawn Gano
- Department of Neurology and Pediatrics, University of California San Francisco, San Francisco, CA, USA.
| |
Collapse
|
45
|
Hase M, Brisch KH, Solomon RM, Hase A. The therapeutic relationship in EMDR therapy-A survey. Front Psychol 2025; 16:1519665. [PMID: 40166400 PMCID: PMC11956297 DOI: 10.3389/fpsyg.2025.1519665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2024] [Accepted: 02/17/2025] [Indexed: 04/02/2025] Open
Abstract
The history of EMDR therapy goes back to 1987, when it was introduced as EMD, a novel treatment for PTSD by Francine Shapiro. Over the course of time EMD developed into the comprehensive therapy approach named EMDR therapy. The development of the Adaptive Information Processing (AIP) Model, the model of pathogenesis and change of EMDR therapy, was a milestone in this development from technique to psychotherapy approach. Lately a description of the therapeutic relationship in EMDR therapy has been proposed based on attachment theory. The therapeutic relationship has been described as a core element of EMDR Therapy, and seems to be related to the structure of EMDR Therapy. An internet-based survey of EMDR therapists in several waves was used to evaluate whether EMDR therapists support the above mentioned description of the therapeutic relationship in EMDR therapy. The self-experience of the EMDR therapists in EMDR therapy as elicited in the survey seems to support the description of the therapeutic relationship in EMDR therapy. Even if the survey was only conducted with EMDR therapists, thus limiting the informative value on the patient population in general, it offers valuable insights into the therapeutic relationship in EMDR Therapy. Implications for treatment, training and research will be discussed.
Collapse
Affiliation(s)
| | - Karl Heinz Brisch
- Institute for Early Life Care, Paracelsus Medical University, Salzburg, Austria
- Dr. von Hauner Children’s Hospital, University of Munich, Munich, Germany
| | | | - Adrian Hase
- Section of Medicine, University of Fribourg, Fribourg, Switzerland
| |
Collapse
|
46
|
Cheatham SW, Baker RT, Loghmani MT, Schleip R. International Expert Consensus on Instrument-Assisted Soft-Tissue Mobilization Precautions and Contraindications: A Modified Delphi Study. Healthcare (Basel) 2025; 13:642. [PMID: 40150492 PMCID: PMC11941819 DOI: 10.3390/healthcare13060642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2025] [Revised: 03/11/2025] [Accepted: 03/13/2025] [Indexed: 03/29/2025] Open
Abstract
Background: Instrument-assisted soft-tissue mobilization (IASTM) is a popular myofascial intervention used by healthcare professionals. Despite the growing body of research evidence, there is still a gap in understanding what healthcare professionals consider as treatment precautions or contraindications. To date, no consensus on precautions and contraindications has been established among IASTM experts. The purpose of this modified Delphi survey was to determine IASTM precautions and contraindications among international IASTM experts. Methods: A three-round Delphi study of 24 international IASTM experts was conducted. In round 1, experts chose from a list of 81 medical conditions and treatment considerations that could be a concern for IASTM treatment. Consensus was considered if more than 70% of experts agreed on an item. Round 2 included the updated list of 39 items, and the experts decided if each item should be a precaution, contraindication, or both. The strength of agreement grade scale was used to rank the precautions and contraindications, by the level of expert agreement using grades A-D (e.g., A-strong, B-moderate, C-weak, D-both). Grade D conditions could potentially be both a precaution and contraindication. In round 3, the final list of categories and items was presented to the experts for final approval. Results: All recruited experts (n = 24) participated in the three rounds and the final list of items received 100% approval. Contraindications had the highest number of conditions (n = 16) across the strength of agreement grade categories A-C followed by category D (both) (n = 8). Discussion: This Delphi study was the first survey to document expert consensus on precautions and contraindications based upon the strength of agreement. This study offers a beginner's guide for clinicians to safely implement IASTM by establishing required precautions and contraindications through consensus agreement. Conclusions: This survey should be the first step in a series of planned IASTM studies on precautions and contraindications to establish the best-practice recommendations for the application of IASTM in clinical practice.
Collapse
Affiliation(s)
- Scott W. Cheatham
- Department of Kinesiology, California State University Dominguez Hills, Carson, CA 90747, USA
- Department of Movement Sciences, University of Idaho, Moscow, ID 83844, USA
| | - Russell T. Baker
- WWAMI Medical Education Program, University of Idaho, Moscow, ID 83844, USA;
- Idaho Office of Underserved and Rural Medical Research, University of Idaho, Moscow, ID 83844, USA
| | - M. Terry Loghmani
- Department of Physical Therapy, Indiana University, Indianapolis, IN 46202, USA;
| | - Robert Schleip
- Conservative and Rehabilitative Orthopedics, TUM School of Medicine and Health, Technical University of Munich, 80333 Munich, Germany;
- Department for Medical Professions, Diploma Hochschule, 37242 Bad Sooden Allendorf, Germany
| |
Collapse
|
47
|
Rraku E, Engwerda A, Medina TD, Swertz MA, Johansson LF, van Ravenswaaij-Arts CMA, Christiaans I. Presenting Clinical Information on Rare Chromosome 6 Disorders via a Parent-Centered Website: Parental and Professional Views. Am J Med Genet A 2025:e64038. [PMID: 40079377 DOI: 10.1002/ajmg.a.64038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2025] [Revised: 02/17/2025] [Accepted: 02/21/2025] [Indexed: 03/15/2025]
Abstract
The scarcity of clinical information surrounding rare chromosome disorders poses challenges for parents and clinicians. To bridge this gap for chromosome 6 disorders, the Chromosome 6 Project collects detailed genotype and phenotype data, aiming to provide aberration-specific phenotype information to parents via an interactive website. With input from 32 parents and 21 professionals, including medical doctors, cytogeneticists, health psychologists, and communication specialists, we used a three-round Delphi method to determine the type and amount of health-related information to be presented on this website. A pre-Delphi questionnaire identified key factors for reporting clinical information online, forming the basis for 13 Delphi statements. Consensus was reached for 12 statements. Participants agreed that clinically relevant features should always be reported given their health impact, while parents also emphasized the importance of issues affecting the child's or family's well-being. Feature prevalence was supported as a guide for the order of reported features. To limit information overload, participants agreed on a reporting threshold for certain features. Finally, parents will be able to tailor the amount and type of information they view, with all details remaining accessible for future reference. While focused on chromosome 6 aberrations, these findings can inform the online information needs of families and professionals dealing with other rare genetic disorders.
Collapse
Affiliation(s)
- Eleana Rraku
- Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
- Department of Clinical Genetics, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands
| | - Aafke Engwerda
- Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
| | - Tyler D Medina
- Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
- Genomics Coordination Centre, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
- School of Mathematical and Statistical Sciences, University of Galway, Galway, Ireland
| | - Morris A Swertz
- Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
- Genomics Coordination Centre, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
| | - Lennart F Johansson
- Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
- Genomics Coordination Centre, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
| | - Conny M A van Ravenswaaij-Arts
- Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
- Autism Team Northern-Netherlands, Jonx/Lentis Psychiatric Institute, Groningen, the Netherlands
| | - Imke Christiaans
- Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
| |
Collapse
|
48
|
Wodnik BK, Namyalo PK, Michaelides O, Essue BM, Kane S, Di Ruggiero E. Implementation science research priorities for Universal Health Coverage: methodological lessons from the design and implementation of a multicountry modified Delphi study. Health Policy Plan 2025; 40:422-427. [PMID: 39658269 PMCID: PMC11886793 DOI: 10.1093/heapol/czae119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2024] [Revised: 11/21/2024] [Accepted: 12/07/2024] [Indexed: 12/12/2024] Open
Abstract
Delphi studies are rapidly gaining prominence in global health research. However, researchers' modifications to the Delphi method are often not well-described or justified, limiting opportunities to systematically learn from these studies when the methods are applied to other topics and settings. This paper aims to describe an approach to implementing a modified Delphi study and reflect on the research process in the context of a multicountry study of implementation science research priorities to advance Universal Health Coverage (UHC). We review trends in the use of the modified Delphi method in global health research, outline our three-phased modified Delphi approach, and share reflections on five decision points for implementing the study: (I) identifying and recruiting participants for the expert panel, (II) addressing participant attrition between rounds, (III) justifying the most appropriate cutoff points, (IV) incorporating new items raised by participants in open-ended survey sections, and (V) ensuring maximum variation in perspective in the panel of experts. Insights from this work foster greater understanding of the underlying assumptions for, and interpretation of, 'modified' in modified Delphi studies. This study will encourage critical dialogue about points of methodological contention in Delphi methodology and thus are relevant for scaling the use of modified Delphi studies in public health, including global health research.
Collapse
Affiliation(s)
- Breanna K Wodnik
- Institute of Health Policy, Management & Evaluation, University of Toronto, 155 College St, Suite 425, Toronto, ON M5T 3M6, Canada
- Centre for Global Health, University of Toronto, 155 College St, Suite 408, Toronto, ON M5T 3M6, Canada
| | - Prossy Kiddu Namyalo
- Institute of Health Policy, Management & Evaluation, University of Toronto, 155 College St, Suite 425, Toronto, ON M5T 3M6, Canada
- Centre for Global Health, University of Toronto, 155 College St, Suite 408, Toronto, ON M5T 3M6, Canada
| | - Ophelia Michaelides
- Centre for Global Health, University of Toronto, 155 College St, Suite 408, Toronto, ON M5T 3M6, Canada
- Dalla Lana School of Public Health, University of Toronto, 155 College St, Suite 500, Toronto, ON M5T 3M7, Canada
| | - Beverley M Essue
- Institute of Health Policy, Management & Evaluation, University of Toronto, 155 College St, Suite 425, Toronto, ON M5T 3M6, Canada
- Centre for Global Health, University of Toronto, 155 College St, Suite 408, Toronto, ON M5T 3M6, Canada
- Dalla Lana School of Public Health, University of Toronto, 155 College St, Suite 500, Toronto, ON M5T 3M7, Canada
| | - Sumit Kane
- Nossal Institute For Global Health, Melbourne School Of Population And Global Health, The University Of Melbourne, Parkville, Victoria 3010, Australia
| | - Erica Di Ruggiero
- Institute of Health Policy, Management & Evaluation, University of Toronto, 155 College St, Suite 425, Toronto, ON M5T 3M6, Canada
- Centre for Global Health, University of Toronto, 155 College St, Suite 408, Toronto, ON M5T 3M6, Canada
- Dalla Lana School of Public Health, University of Toronto, 155 College St, Suite 500, Toronto, ON M5T 3M7, Canada
| |
Collapse
|
49
|
Alghazawi LOK, Mavroveli S, Anastasiou E, Attia M, Johnson N, Campioni-Norman D, Amiras D, Ladas A, Boland MR, Hanna G, Thiruchelvam PT, Leff DR. Validation of a simulator for oncoplastic breast conserving surgery. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2025; 51:109753. [PMID: 40086215 DOI: 10.1016/j.ejso.2025.109753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2025] [Revised: 02/26/2025] [Accepted: 03/06/2025] [Indexed: 03/16/2025]
Abstract
BACKGROUND Therapeutic Mammoplasty (TM) is increasingly becoming the standard of care, especially for patients with large tumor-to-breast volume ratios. The wider dissemination of oncoplastic skills warrants systems for the acquisition and assessment of safe skills. To date, TM simulations have not been developed for the acquisition or assessment of oncoplastic skills. This study aimed to design, develop, and validate a synthetic TM simulator for specialist surgical training and assessment. METHODS A prospective, observational, and survey-based study. Breast surgeons collaborated with designers to construct a TM simulator. A modified Delphi approach was used to create a Competency Assessment Tool (CAT). Surgeons with varying operative experience performed simulated vertical scar TM. Procedures were videotaped (blinded, pseudo-anonymized), subsequently reviewed, and independently rated against CAT by three experts. Specimen radiographs and volumetric analysis were performed to assess specimen weight(g), volume(cm3), and adequacy of resection, derived as a percentage of deviation in uniformity around a 10 mm margin. RESULTS Thirty participants were recruited (10 consultants, 10 senior registrars (ST7-8), and 10 junior registrars (ST3-6)). Video-based rating scores (0-40) were significantly greater in consultants (median(IQR) = 34.0(30.5-38.0)) than in senior registrars (median(IQR) = 30.0(28.0-33.0)) and junior registrars (median(IQR) = 28.0(25.8-30.3)). The CAT scores varied significantly based on operator grade (p < 0.05). The inter-rater reliability showed fair agreement (κ = 0.379). Specimens resected by consultants had significantly greater weight and volume (p < 0.05). The consultants demonstrated the greatest uniformity in resection accuracy (p < 0.05). CONCLUSION A novel oncoplastic simulator was developed to practice and assess TM skills. Video-based ratings and end-product assessments differentiated experts from novice surgeons, suggesting construct validity.
Collapse
Affiliation(s)
- Laith O K Alghazawi
- Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Breast Unit, Imperial College Healthcare NHS Trust, London, United Kingdom
| | - Stella Mavroveli
- Department of Surgery and Cancer, Imperial College London, London, United Kingdom
| | - Eleni Anastasiou
- Department of Surgery and Cancer, Imperial College London, London, United Kingdom
| | - Mohamed Attia
- Breast Unit, Imperial College Healthcare NHS Trust, London, United Kingdom; Department of General Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt
| | - Natalie Johnson
- Breast Unit, Imperial College Healthcare NHS Trust, London, United Kingdom
| | | | - Dimitri Amiras
- Department of Surgery and Cancer, Imperial College London, London, United Kingdom
| | - Andreas Ladas
- Breast Unit, Imperial College Healthcare NHS Trust, London, United Kingdom
| | - Michael R Boland
- Breast Unit, Imperial College Healthcare NHS Trust, London, United Kingdom
| | - George Hanna
- Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Breast Unit, Imperial College Healthcare NHS Trust, London, United Kingdom
| | | | - Daniel R Leff
- Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Breast Unit, Imperial College Healthcare NHS Trust, London, United Kingdom.
| |
Collapse
|
50
|
Perreault T, Dommerholt J, Fernandez-de-las-Peñas C, Arendt-Nielsen L, Cagnie B, Di Antonio S, Castaldo M. Expert Consensus on Dry Needling Practices for Headache: An International Delphi Study Protocol. J Clin Med 2025; 14:1740. [PMID: 40095844 PMCID: PMC11900175 DOI: 10.3390/jcm14051740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2025] [Revised: 02/26/2025] [Accepted: 03/03/2025] [Indexed: 03/19/2025] Open
Abstract
Background: Dry needling is increasingly utilized by clinicians in the treatment of patients with headaches. Although current evidence supports the use of dry needling for reducing headache pain, needling approaches are inconsistent among published studies, and no guidelines on dry needling for headaches have been established. Methods: A study will be conducted using the Delphi method, consisting of three rounds of questionnaires sent to an expert panel of clinicians and researchers. Results: To guide the development of the initial survey, we completed a literature review of articles related to dry needling for headaches. A steering committee will assess the initial survey items synthesized from the literature search and provide recommendations for the first and subsequent rounds of the study. Percentage agreement will be the primary measure throughout all rounds of this study. We define consensus to have been reached when 75% agreement is achieved. Conclusions: We seek to develop clinical recommendations that will guide research and treatment practices regarding dry needling for headaches. Having consensus-driven recommendations on dry needling for headaches will assist researchers in the design of future studies on this condition. In addition, having guidelines that clinicians can reference prior to the delivery of dry needling for headaches would benefit patient care.
Collapse
Affiliation(s)
- Thomas Perreault
- Department of Physical Therapy, Wentworth Douglass Hospital, Dover, NH 03820, USA
| | | | - César Fernandez-de-las-Peñas
- Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Madrid, Spain;
- Cátedra Institucional en Docencia, Clínica e Investigación en Fisioterapia-Terapia Manual, Punción Seca y Ejercicio Terapéutico, Universidad Rey Juan Carlos, 28922 Madrid, Spain
| | - Lars Arendt-Nielsen
- Center for Neuroplasticity and Pain, SMI, School of Medicine, Aalborg University, DK-9220 Aalborg, Denmark; (L.A.-N.); (S.D.A.); (M.C.)
- Department of Gastroenterology & Hepatology, Mech-Sense, Clinical Institute, Aalborg University Hospital, DK-9000 Aalborg, Denmark
- Steno Diabetes Center North Denmark, Clinical Institute, Aalborg University Hospital, DK-9000 Aalborg, Denmark
| | - Barbara Cagnie
- Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine, and Health Sciences, Ghent University, Campus Heymans, 9000 Ghent, Belgium;
| | - Stefano Di Antonio
- Center for Neuroplasticity and Pain, SMI, School of Medicine, Aalborg University, DK-9220 Aalborg, Denmark; (L.A.-N.); (S.D.A.); (M.C.)
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal Child Health, University of Genoa, 16132 Genoa, Italy
| | - Matteo Castaldo
- Center for Neuroplasticity and Pain, SMI, School of Medicine, Aalborg University, DK-9220 Aalborg, Denmark; (L.A.-N.); (S.D.A.); (M.C.)
- Department of Medicine and Surgery, Clinical Psychology, Clinical Psychophysiology and Clinical Neuropsychology Labs., University of Parma, 43121 Parma, Italy
| |
Collapse
|